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S U M M A R Y
Angiotensin II, the e ffe c to r peptide o f the renin-angiotensin system, acts 
on its  ta rg e t cells v ia  specific  membrane receptors. P la te le ts  were prepared 
from  peripheral venous blood (60 m l) by cen trifuga tion  through an iso-osm otic 
so lution o f P e rco ll, resu lting in a good recovery o f cells (50-90%, n=192), 
re la tiv e ly  free  o f eryth rocytes ( <0.1% ) and leukocytes (< 1 % ). Specific  binding 
o f ^2^1-angiotensin II (300 pmol/1) to  p la te le ts  was iden tified . This was tim e 
and tem pera ture dependent, saturable, reversib le  and linear w ith  p la te le t 
concentra tion. Scatchard analysis o f satura tion  curves revealed a single class o f 
binding sites w ith  Kd 1.5 + 0.4 x 10"^^ mol/1 and to ta l binding capacity  6.3 +
1.2 re ce p to r/p la te le t. S im ila r values (Kd 2.4 + 0.7 x lO ’ ^^ mol/1, and binding 
capacity 6.5 + 1.0 recep to r/p la te le t) were obtained from  displacement analysis. 
From  k in e tic  studies the fo rw ard  and reverse ra te  constant were 3.1 x  ID® mol 
m in ~ ^ r^  and 3.6 x lO '^m in "^  giving a Kd o f 1.2 x 10"^^ mol/1. The re la tiv e  
binding potencies fo r  angiotensin II and analogues were: [S ar^, Thr® ]-Ang 
II > Ang I I  > Ang III  > [ Sar^,AIa®] -Ang II > Ang I, these are s im ila r to  those 
described fo r  ra t adrenal cells. P re trea tm ent w ith  cap top ril 'in  v ivo ' and 
angiotensin II 'in  v ivo ' and 'in  v itro ' did not a lte r receptor cha racte ris tics . 
Studies w ith  a D-phenylalanine, showed th a t spec ific  binding was not a ffe c te d  by 
th is  carboxypeptidase A Inh ib ito r. Incubation w ith  an ex tra ce llu la r f lu id  m arker 
(51cr-labe lled  EDTA) demonstrated th a t binding o f angiotensin I I  to  p la te le ts  
was by a specific  receptor mechanism and not due to  free  flu id  endocytosis.
The e ffe c t o f changes in d ie ta ry  in take o f sodium and potassium on 125i_ 
angiotensin II binding to  p la te le ts were studied in e ight normal subjects. 
R e s tr ic tio n  o f sodium in take (15 m m ol/day) resulted in a decrease in  the number 
o f receptor sites from  6.2 + 0.3 s ite s /p la te ie t to  4.1 + 0.4 s ite s /p la te ie t
(p< 0.01) but there were no changes in a f f in ity  (Kd). Over a range o f sodium
intakes from  15 to  200 m m ol/day (high sodium d ie t) there was a co rre la tion
between plasma concentration o f angiotensin II and receptor s ite  concentration 
(r^  0.57, p <0.01). S im ila r changes in  the density o f angiotensin II binding sites 
have been described in vascular smooth muscle. Changes in d ie ta ry  potassium 
in take from  normal (70 m m ol/day), to  low  (35 m m ol/day) or high (150 m m ol/day) 
did not a ffe c t angiotensin II binding.
Angiotensin II binding was measured in ten patients w ith  essential 
hypertension (mean blood presure 178/107 mmHg, plasma concentrations o f renin 
1 2 + 2  uU /m l and angiotensin II 14 + 2 pg/m l) and ten subjects w ith  normal 
blood pressure (mean blood pressure 112/74 mmHg, plasma concentrations o f 
ren in  13 + 2 uU /m l and angiotensin II 13 + 2 pg/m i). The binding capacity  and
a ff in ity  (Kd 5.0 ±  0.6 x 1D"^®M, 5.7 + 0.8 s ites /ce ll) in the hypertensive patients
were s im ila r to  values in the normotensive subjects (Kd 4.9 + 0.8 x lO '^ ^ M , 5.4 
+ 0.5 sites/ce lls). Changes in  sens itiv ity  to  angiotensin II in  essential 
hypertension may not be determ ined at receptor level.
The e ffec ts  o f angiotensin II on p la te le t function  were also studied. 
Angiotensin II (10"^^ -  lO '^M ) alone had no e ffe c t on p la te le t aggregation and 
did not increase the cytoso lic  free  C a^* concentration fo llow ing  e ithe r short (<2 
min) o r long term  (30 m in) incubation o f Quin 2 labelled p la te le ts . No 
s ign ifican t increase or decrease in thromboxane B2 production fro m  p la te le ts  in 
response to  angiotensin II was observed.
However, the secondary phase o f adrenaline-induced p la te le t aggregation 
was s ign ifican tly  augmented by angiotensin I I .  A low  concentra tion  o f 
angiotensin II ( lO '^ M )  enhanced the e ffec ts  o f adrenaline, whereas higher 
concentrations (10"^M) inh ib ited aggregation; angiotensin had no e ffe c t on AD P- 
induced aggregation. The fa c il ita to ry  e ffe c t o f angiotensin II on p la te le t
aggregation was prevented by p re -trea tm en t o f p la te le ts  w ith  flu rb ip ro fen  
ind ica ting  th a t angiotensin II e ithe r, stim ulates the release o f, or potentia tes the 
actions o f thromboxane A 2 (the m edia tor o f adrenaline-induced secondary 
aggregation). Angiotensin II (10"^^ -  10"^M) enhanced the e ffe c ts  o f the stable 
thromboxane A2 m im e tic  U44069 on p la te le ts but synthesis o f thromboxane 82, 
the stable and in e rt product o f thromboxane A2 m etaboiism , was inh ib ited. The 
pro-aggregatory e ffe c ts  o f low  concentrations o f angiotensin II on p la te le ts are 
probably due to  fa c il ita t io n  o f the e ffec ts  o f thromboxane A 2.
C H A P T E R  1 IN T R O D U C T IO N
1.1 TH E R E N IN -A N G IO T E N S IN  SYSTEM
Renin was discovered in  1898 by T igersted t and Bergman as a pressor 
m ate ria l in ex trac ts  o f renal co rtex  (T igerstedt and Bergman 1898). I t  is now 
known th a t renin is an aspartic  proteinase, synthesised and secreted m ain ly by 
the ep ithe lia l cells o f the juxtag lom eru la r apparatus in  the renal co rtex  (review , 
Davis and Freeman 1976). I t  acts on its  substrate (angiotensinogen), an o - 
globulin synthesised by the liv e r , to  produce an inactive  decapeptide, angiotensin 
I. The renin-substrate reaction  takes place in blood but may also occur w ith in  
blood vessel walls. Subsequently, angiotensin I is cleaved by a pep tidy l dipeptide 
hydrolase (angiotensin I  converting enzyme), which is m a in ly present on the 
membrane o f endothelia l ce lls from  the pulmonary and system ic vasculature. 
This enzyme removes a dipeptide from  the carboxyl te rm ina l o f the decapeptide 
to  produce the vasoactive octapeptide angiotensin II (Vane 1972). The cleavage 
o f angiotensin II by a v a rie ty  o f angiotensinases produces a number o f sm aller 
peptides, one o f which, the heptapeptide angiotensin III, is also physio log ica lly 
ac tive  (B la ir-W est, Coghlan, Denton, Funder, Scoggins and W righ t 1971). The 
b iochem ical pathways o f the renin-angiotensin system are shown in  F igure 1.1.
The octapeptide, angiotensin II is the m ajor ac tive  component o f the 
renin-angiotensin system in man. The concentration o f angiotensin II in human 
peripheral plasma is around 20 pM (Morton, Sempie, W aite, Brown, Lever and 
Robertson 1976)
Angiotensin II is one o f the most powerfu l constric to rs  o f a r te r ia l smooth 
muscle. I t  also has an im portan t ro le  in regu la ting e x tra ce llu la r f lu id  volume by 
a ffe c tin g  aldosterone secretion from  the adrenal co rtex  and by d ire c t e ffe c ts  on
Angiotensinogen
Renin
Angiotensin I
Converting enzyme
Angiotensin I I
Pressor e ffe c t  
Sympathetic stim ulation
ADH secretion
Aldosterone secretion
Thirst
Renal actions
F IG U R E  1.1  O utline  o f the renin-angiotensin system and some o f the main 
actions o f angiotensin II.
renal func tion . In  addition i t  may in te ra c t w ith  the sym pathetic nervous system 
and be a fa c to r  in  the regu la tion o f a n ti-d iu re tic  hormone secretion.
The physiological e ffec ts  o f angiotensin II are in it ia te d  by hormone 
in te rac ting  w ith  its  spec ific  receptors.
1.2 H O R M O N E A C T IO N
1.2:1 D e fin itio n  o f a hormone
A  hormone is a substance released from  endocrine glands in to  the 
c ircu la tion , th a t contro ls the function  o f spec ific  ta rge t tissues. This d e fin itio n  
has been widened to  include substances like  angiotensin II, which are not 
synthesised by endocrine glands but have regu la tory  properties cha rac te ris tic  o f a 
hormone. The s p e c ific ity  o f hormone action in a pa rticu la r ta rg e t tissue is due 
to  recogn ition  o f the hormone by a receptor. In te rac tion  o f the hormone w ith  
its  recep to r in itia te s  a chain o f biochem ical events which characterise the 
physiological response. The receptor concept can be traced back to  Langley's 
work (1906) on the action o f n icotine and curare on muscle. He described a 
specific  receptive  substance, which received the stim ulus and, by tra n sm ittin g  i t ,  
caused con trac tion . An extension o f the receptor concept came from  the work 
by E hrlich  (1900), who found th a t tetanus tox in  f i r s t  combines w ith  ce rta in  groups 
in the protoplasm o f cells, and th a t th is  chem ical com bination is responsible fo r  
the poisonous e ffe c ts . He named these chem ical groups 'receptors'. C la rk  (1926 
a &  b) made s im ila r conclusions from  his observation o f ace ty lcho line  and 
atropine action . He showed th a t the very sm all quantities o f drug (about 20,000 
molecules per ce ll) were required to  produce a ce llu la r response, were co rre la ted  
w ith  the number o f receptors present in  responsive cells. He also pointed out 
th a t drug-receptor com bination obeyed the law o f mass action. Since then, the
idea o f receptors has become f irm ly  established. From classical dose-response 
studies in tissues using hormone agonists and antagonists i t  became possible to  
classify receptors. The recogn ition o f the alpha- and beta-adrenoreceptor by 
Ah lqu ist is an example o f th is approach (Ah lqu ist 1948). From  such in d irec t 
studies w ith  hormone antagonists i t  was also possible to  ca lcu la te  receptor 
a f f in ity  (Schild 1949). Over the las t 15 years, i t  has been possible to  measure 
recep to r binding d ire c tly  using rad io -labe lled  hormones and drugs. These rad io­
ligand binding techniques have been applied to  receptors fo r  a great number o f 
pharm acological active  agents (Cuatrecasas and Hollenberg 1976; B lecher 1976). 
These methods depend on techniques to  distinguish receptor binding from  
b iochem ica lly  unim portant non-specific binding.
1.2:2 The second messenger concept
I t  is doubtfu l tha t any hormone d ire c tly  a ffec ts  the physiological process 
which i t  u ltim a te ly  controls. In most cases there is a t least one in te rm ed ia ry  
in tra ce llu la r step between receptor binding and the fin a l b iochem ical event. In 
1936 Sutherland e t al. (Sutherland and W osila it 1956) incubated dog liv e r  slices 
w ith  epinephrine and measured its  e ffe c t on the a c t iv ity  o f glycogen 
phosphorylase. Phosphorylase a c t iv ity  was gradually los t unless epinephrine was 
added which then restored fu ll a c tiv ity . R a il e t al. (R a il, Sutherland and 
B e rthe t 1957) demonstrated th a t a heat-stable dialysable fa c to r  was produced 
fo llow ing  the in te rac tion  o f epinephrine w ith  liv e r  ce ll membranes. This fa c to r  
then ac tiva ted  the phosphorylase a c t iv ity  and was subsequently id e n tif ie d  as 
cy c lic  AMP.
These findings led to  the second messenger concept. The hormone ( f irs t  
messenger) in te rac ts  w ith  the receptor s ite  which is located a t the plasma 
membrane or c e ll surface. This in te rac tio n  leads to  an increase (or decrease) in 
the a c t iv ity  o f adenylate cyclase (a component o f the ce ll membrane), which
results in change o f the in tra ce llu la r concentrations o f cy c lic  AM P. This 
increase in cyc lic  AMP is responsible fo r  the hormone induced changes in ce ll 
function . The actions o f many hormones, including most o f the peptide 
hormones and also the g-adrenergic agonists, were found to  be m ediated by 
cyc lic  AM P. One im portan t exception is the stim u la tion  o f glucose uptake in to 
ce lls by insulin which seems to  be independent o f cy c lic  AMP. Since insulin 
does not enter the cells o f its  ta rg e t tissue, perhaps the insu lin -receptor 
complex in te racts  w ith  functiona l macromolecules in the membrane. Besides 
insulin, there are several hormones th a t do not s tim u la te  adenylate cyclase 
including angiotensin, growth hormone, ct-adrenergic catecholam ines, epiderm al 
grow th fa c to r, fib rob las t grow th fa c to r, insu lin -like  grow th fa c to r, oxytoc in , 
p ro lac tin , somatomedin and som atostatin (Baxter and Funder 1979).
1.2:3 C lassifica tion  o f receptors
A lthough receptors fo r various classes o f hormone share functiona l 
properties, they d iffe r  in ce llu la r loca lisa tion, post-binding tran s fe r o f 
in fo rm ation  and the particu la r hormones th a t they recognise. There are three 
types o f hormone receptor:
(1) Receptors fo r  peptide hormones (including releasing fac to rs ) and 
catecholam ines, which are located on the plasma membrane o f ta rg e t tissue 
ce lls. I t  has been demonstrated th a t many hormones w ith  membrane receptors 
produce th e ir  physiological e ffe c ts  w ith o u t penetrating the ce ll.
(2) Steroid hormones penetrate the ce ll easily. Cytoplasm ic receptors bind w ith  
the steroids and th is complex is transferred to  the nucleus where i t  in itia te s  
transcrip tion  events leading to  the ^  novo synthesis o f proteins.
(3) Thyroid hormone receptors are found in the ce ll nucleus. Thyro id  hormones 
penetrate cells to  bind the receptors in  the chrom atin o f  the nucleus (Baxter 
and Funder 1979).
1.2:4 Chem ical properties o f membrane receptors
In 1976, no hormone or neurotransmitter receptor had been
isolated of sufficient quality and quantity for complete
chemical characterisation. However, since then, there has been
considerable progress in our understanding of the chemical
nature of receptors. Several membrane receptors such as
acetylcholine and insulin have been isolated, purified and
chemically characterised.
A ll known hormone receptors contain a pro te in  component which is
im portan t fo r  hormone recogn ition. This can be degraded by a va rie ty  o f 
p ro teo ly tic  and peptidase enzymes (Kahn 1975). Several receptors such as 
adrenocorticotrophin (ACTH), glucagon, thyro trop in  releasing hormone and both 
the adrenergic and cho linerg ic neurotransm itters, exh ib it decreased hormone 
binding a fte r  phospholipase trea tm en t, suggesting th a t these receptors also 
contain a s ign ifican t phospholipid component (Kahn 1976). The receptors fo r 
insulin, thy ro trop in  and gonadotropins have been reported to  contain carbohydrate 
m oieties. D isu lfide groups have not been shown to  be necessary fo r  any 
horm one-receptor in te rac tion , although the LH  receptor appear to  need 
su lfhydry l groups fo r  the maintenance o f its  b io log ica lly  ac tive  conform ation 
(Dufau, Ryan and C a tt 1974).
Most peptide hormone receptors which have been solubilised are large 
molecules and have had estim ated m olecular weights o f about 200,000 daltons 
(ranged from  140,000 to  550,000) (C a tt and Dufau 1977). Many receptors also 
seem to  have tw o  or more sm aller subunits, which toge ther fo rm  the whole 
receptor complex, which binds to  the hormonal ligand. These o ligom eric 
receptors, like  insulin and acetylcho line, o ften  in te rac t cooperative ly w ith  each 
other e ithe r pos itive ly  or negative ly to  increase the se n s itiv ity  o f the c e ll to  
low hormone concentrations and p ro tec t against high concentrations (Kahn 1975;
Kahn 1976)
The number o f receptors fo r  most hormones range from  2,000 to  100,000 
per ce ll. Hormone binding to  only 1% -  5% o f receptors w ill o fte n  tr ig g e r a 
b io log ica l response. This allows low concentrations o f hormones to  bind w ith  a 
re la tiv e ly  sm all quan tity  o f receptor to  induce a b io log ica l response (C a tt and 
Dufau 1977)
A ttem p ts  to  p u rify  and chem ica lly characterise hormone receptors have 
proceeded slow ly because o f the sm all number o f molecules per c e ll and the 
re la tiv e ly  in so lub ility  o f these macromolecules. However, so lubilisa tion (Gavin, 
Buell and Roth 1972) allows the receptors to  re ta in  high binding a f f in ity  and 
s p e c ific ity  o f binding properties. Further, studies on the s tru c tu ra l and 
im m unological properties o f the acetylcholine receptors have benefited fro m  the 
app lica tion o f a f f in ity  chromatographic procedures (R a fe rty  1975) which enables 
the p u rifica tio n  o f large quantities o f receptor sites from  ta rg e t tissues.
In summary, the receptor may be defined as a h igh ly se lective  chem ica l 
recogn ition fa c to r, present in or on cells in very sm all numbers, which a fte r  
in te rac tin g  w ith  spec ific  hormonal compounds, consequently a lte rs  some c r it ic a l 
b iochem ical process so as to  in it ia te  a generalised b io log ica l response 
(Hollenberg and Cuatrecasas 1979).
1.3 H O RM O NE RECEPTORS
The basic methodology employed fo r  most d irec t studies o f hormone- 
receptor in te rac tion  is s im ila r to  o ther com petitive  pro te in  binding assays (Kahn 
1975). A  radio labelled hormone or hormone com petitive  antagonist is  incubated 
e ithe r w ith  whole cells or w ith  a subcellu lar fra c tio n  o f ce lls. A f te r  a period 
o f incubation, the hormone-receptor complex is separated from  the free  hormone
by cen trifuga tion , f i lt ra t io n  or p rec ip ita tion , and the receptor bound ra d io a c tiv ity  
is determ ined. The sp e c ific ity  and sa tu rab ility  o f th is  reaction  are determ ined 
by incubation w ith  various concentrations o f unlabelled hormone o r re la ted  
compounds. Méthodologie problems re la te  to  the choice o f appropria te labelled 
hormone, d is tin c tion  o f receptor from  non-receptor binding, preparation o f tissue 
fo r  binding studies, techniques o f separating free  from  bound ligand and 
m athem atica l description o f binding isotherms.
1.3:1 Radiolabelled hormone
The rapid progress in the understanding o f the receptor m ediated 
mechanisms since 1960 can be a ttr ib u te d  to  the development o f methods fo r  
rad io labe lling  hormones th a t give high specific  a c t iv ity  w ith o u t a ffe c tin g  
b io log ica l a c tiv ity . For many peptide hormones i t  is possible to  a tta in  a higher 
specific  a c t iv ity  labelling w ith  125j (gj. l ^ l j j  than w ith  or
T heo re tica lly , would y ie ld monoiodohormone w ith  higher spec ific  a c t iv ity
( 16,200 C i/m m o i) than ( r - - ,  2,300 C i/m m o l) i f  both were available in  an
iso top ica lly  pure fo rm . However, is pre ferred fo r  the fo llow ing  reasons: (1) 
i t  is c a rrie r-fre e , i.e ., close to  100% isotopic abundance, whereas the m axim al 
isotopic abundance o f does not exceed 30% (Berson and Yalow  1973), (2) i t  
has a longer h a lf l i fe  (60 vs 8 days) than (3) i t  is counted w ith  g reater
e ffic ie n cy  in most gamma counters (Blecher 1976).
O ther isotopes such as ^H , y ie ld  ligands w ith  much low er spec ific
ra d io a c tiv ity , are lim ite d  in detecting the sm all numbers o f peptide recep to r 
sites in ce ll membranes (Kahn 1975). However, the ^H -labe lling  has proven 
most useful w ith  sm aller peptide hormones such as vasopressin (Jard 1983) and 
oxytoc in  (Kahn 1975).
Iodine is a iarge molecule and the spatia l arrangement or m olecu lar 
conform ation o f proteins and peptides are complex. Incorporation o f iodine in to
the hormone m olecule such as argin ine vasopressin may cause conform ationa l 
changes resu lting  in loss o f b io log ica l a c t iv ity  (Moore, H u ffm an, Roberts, 
Rottschaefers, Sulat, S tefanklew icz and Stassen 1984).
In choosing appropriate conditions fo r  binding studies, i t  is also im po rtan t to  
select a tem pera ture th a t m inim ises both receptor and ligand degradation but 
perm its the a tta inm en t o f equ ilibrium  conditions in a reasonable tim e . I t  is also 
necessary to  choose a method o f separating free  from  receptor-bound ligand th a t 
is appropriate fo r  the expected ra te  o f ligand dissociation. These considerations 
are as im portan t as the c r ite r ia  necessary to  establish th a t binding has the 
characteris tics expected o f a receptor mechanism (Jacobs and Cuatrecasas 1981). 
1.3:2 C r ite r ia  fo r  receptor in te rac tion
I t  is essential to  distinguish binding o f a ligand to  receptor sites (specific  
binding) from  binding to  other sites on or in the ce ll (nonspecific). Hormone 
receptor in teractions are characterised by (1) high a ff in ity ,  appropriate fo r  low  
concentration o f hormone, (2) sa tu rab ility , ind ica ting  a f in ite  number o f binding 
sites (3) re v e rs ib ility , consistent w ith  loss o f the physiological e ffe c ts  upon 
rem oval o f hormone from  the medium, (4) sp e c ific ity , agonists and co m pe titive  
antagonists compete fo r  binding w ith  the same rank order o f a f f in ity  as found in 
dose-response studies, (5) a d is tribu tion  among tissues consistent w ith  the known 
a c tiv itie s  o f the hormone (Hollenberg and Cuatrecasas 1979).
1.3:3 Receptor preparations
Binding to  hormone receptors may be studied in in ta c t cells, pa rticu la te  
fractions o f cells and solubilised frac tions o f ce lls. Each has advantages and 
disadvantages. Isolated in ta c t ce ll preparation can be obtained from  blood, 
tissue cu ltu re  or by enzym atic or mechanical d isruption o f tissues. In ta c t ce lls 
are usually m etabo lica lly  active , making i t  possible to  measure both binding and 
hormone e ffec ts  in the same preparation, and to  express the concentra tion o f
binding sites per ce ll. This Is p a rticu la rly  useful in comparing the changes in 
hormone-binding between various physiological and pathological conditions. 
However, there are problems w ith  in ta c t ce lls. Degradation o f hormone during 
incubation may be higher in in ta c t cells than In subcellular frac tio ns , and the 
concentration and a ff in ity  o f hormone receptors may be a ffe c ted  by enzym atic 
digestion and o ther tissue iso la tion and cu ltu re  techniques. A  fu rth e r problem 
re lates to  contam ination o f the preparation by cells o f a d iffe re n t type (Kahn 
1976; B lecher 1976).
Receptors may be studied in pa rticu la te  ce ll frac tions and th is  has some 
advantages. These include s ta b ility  during storage, less hormone degradation, 
and decrease In nonspecific hormone binding. I t  should be emphasized th a t even 
in highly purified  plasma membrane preparations these problems may s t i l l  occur. 
Membrane preparations may not be representative o f to ta l plasma membrane and 
may also be contam inated by membranes from  cells o f another type. F o r th is 
reason, membrane preparations must be assessed fo r  y ie ld , p u r ity  and 
contam ination w ith  other organelles (N eville  and Kahn 1974).
Solubilised fractions o f cells and ce ll membranes may re ta in  the hormone 
binding characteristics o f receptor sites on in ta c t cells or plasma membranes. 
N eu tra l and anionic detergents, anionic b ile  salts, phospholipid emulsions, lith iu m  
d iiodosa licyla te , and even lim ite d  p ro te o ly tic  digestion have been used (C a tt and 
Dufau 1977). Solubilisation is a necessary prerequisite to  p u r if ic a tio n  and 
characterisa tion o f the receptor molecules (Cuatrecasas 1972). Problems of 
heterogeneity and contam ination o f the orig ina l preparation may s t i l l  be present 
in solubilised preparations. In  add ition , residual detergent required to  m ain ta in  
the binding proteins in a soluble s ta te  may compromise precise physical 
measurement. Labelled hormone may associate w ith  detergent m ice lles and 
fo rm  a complex which could be m istaken fo r  horm one-receptor complexes
(G iorgio, Johnson and B iecher 1974).
1.3:4 Receptor detection
Rapid and e ff ic ie n t separation o f bound ligand fro m  the supernatant 
medium in in ta c t ce lls, membranes or solubilised receptors can be achieved:
(1) By cen trifuga tion . This is perhaps the sim plest and m ost rapid technique fo r 
separating cells or subcellu lar pa rticu la te  frac tions  from  suspensions.
(2) By f i lt ra t io n  through cellulose or glass fib re . Im po rtan t fac to rs  in this 
technique are pore size, choice o f m a te ria l and degree o f nonspecific binding o f 
ligand to  the f i l te r .  In  addition, f i lt ra t io n  is usually slower than cen trifuga tion  
and the process may be im paired i f  ce ll or membrane concentra tion is too high.
(3) By gel f i l t ra t io n . This has been used to  separate membrane and solubilised 
receptors such as adrenergic receptors in  toad e ry th rocyte  vesicles (Sahyoun, 
Hollenberg, Bennett and Cuatrecasas 1977) but has the disadvantage th a t i t  is 
slow and hence gives less binding because of the separation o f hormone and 
receptor complex during chrom atography (Cuatrecasas 1972).
(4) By p rec ip ita tion . Polyethylene glycol a t appropriate concentrations 
precip ita tes receptor-bound hormone, w h ile  the free  hormone remains in solution. 
This method has been applied to  the measurement o f solubilised receptor 
binding, insulin is a pa rticu la r example (Cuatrecasas 1972). An im portan t 
consideration in the choice o f method fo r  separating free  from  recep to r bound 
ra d io a c tiv ity  is the ra te  o f dissociation o f the horm one-receptor complex.
1.3:5 O ther problems in  horm one-receptor binding assay
Temperature is a c r it ic a l fa c to r in determ ining horm one-receptor 
in teractions. The rates o f association and dissociation and the to ta l amount o f 
receptor binding are tem pera ture  dependent. A t  low er tem peratures equ ilib rium  
is a tta ined more slow ly but the to ta l amount o f receptor binding is increased. 
This increase in  binding is in  part due to  increased a f f in ity  (Kahn, F reychet,
Roth and N ev ille  1974). Tem perature has o ther and probably more im portan t 
e ffec ts  in a radio-ligand binding assay. A t  low er tem peratures the ra tes o f 
hormone and receptor degradation are reduced, a fa c to r o f pa rticu la r im portance 
fo r angiotensin II which is susceptible to  degradation by several protease 
enzymes present in plasma and tissues.
The ra te  o f degradation is also in fluenced by the amount o f membrane in 
the preparation.
1.3:6 Analysis o f receptor binding data
Binding data may be analysed in  several ways. I have usually expressed 
the binding o f labeiled-horm one as counts per m inute (cpm) bound or as a 
percentage o f to ta l ra d io a c tiv ity  bound, p lo tted  as a function  o f the 
concentration o f unlabelled hormone in the Incubation medium. This results in  a 
displacement curve w ith  decreasing concentrations o f unlabelied hormone. 
Binding o f hormone is also expressed as percent o f in it ia l binding (100 x B/Bo)
where Bo represents the binding o f labelled hormone in the absence of
unlabelled hormone. Binding is also p lo tted  as the ra tio  o f bound (B) to  free  
(F), or B /F . In  most instances, binding has been expressed as spec ific  binding, 
th a t Is a fte r  subtraction  o f nonspecific binding. Nonspecific  binding was defined 
as binding o f radio ligand in the presence o f 2.5 pM  unlabelied angiotensin I I .  In 
analysis o f the displacement curves, the amount o f hormone bound was 
calculated as B/Bo x B j  where B = spec ifica lly  bound hormone (cpm) and B y  = 
to ta l hormone binding (cpm). Scatchard analysis has been used to  characterise
receptor binding. In  th is  method, the B /F  ra tio  is p lo tted  as a function  o f
concentration o f bound hormone. The resu ltan t p lo t linearises the binding data 
and perm its the ca lcu la tion o f both the a f f in ity  constants (Kd) and binding 
capacities (Bmax) (Scatchard 1949). Binding capacity may then be expressed as 
a function  o f the concentration o f cells, membrane prote in , or solubilised
fra c tio n  o f p ro te in  in the medium.
Scatchard p lots may be linear o r nonlinear. N on-linea rity  o f Scatchard 
plots may re fle c t (1) positive ligand-ligand coope ra tiv ity  (concave down) (2) 
negative ligand-ligand coope ra tiv ity  (concave up) (3) simultaneous binding o f a 
ligand a t tw o  or more sites (concave up) (4) d ifferences in a f f in ity  o f labelled 
ligand (concave up) (5) inaccurate determ ination o f the portion o f bound and 
free  ligand (concave up) and (6) lack o f com plete binding equ ilib rium  
(Cuatrecasas and Hollenberg 1976). An example o f curv ilinear Scatchard plots 
o f angiotensin II were described in bovine adrenal cortex and a ttr ib u te d  to  the 
presence o f more than one class o f binding sites (Glossman, Baukal and C a tt 
1974a).
1.4 A N G IO TEN SIN  I I  RECEPTORS
Angiotensin II a t concentrations which are found in plasma (10"^^M ) has 
been shown to  a ffe c t many tissues. For example, smooth muscle in  blood 
vessels, gut, uterus and bladder con trac t, zona glomerulosa cells o f the adrenal 
co rtex  secrete aldosterone, renal tubu la r func tion  is a ltered and there  are also 
e ffec ts  in  the sym pathetic nervous system have been demonstrated (Brown, 
Leckie , Lever, M cIn tyre , M orton, Semple and Robertson 1983) in response to  
physiological concentrations o f angiotensin. Responsiveness to  angiotensin I I  by 
a p a rticu la r tissue can be varied in  a specific  manner. I t  is lik e ly  th a t 
sp e c ific ity  and v a r ia b ility  in responsiveness re f le c t d ifferences in angiotensin II 
receptor properties. Much work has been done to  id e n tify  and characterise 
receptors fo r  angiotensin in d iffe re n t tissues w ith  a view to  expla in ing the 
physiologicai e ffe c ts  o f the hormone.
1.4:1 D is tribu tion  and binding characte ris tics  o f angiotensin II receptors
M ost o f the in fo rm ation  about angiotensin II receptors has been derived 
from  anim al studies (see Table 1.1). A l l tissues which respond to  angiotensin II 
have been shown to  have appropria te receptors. G enerally the dissociation 
constant is around 1 nM which is com patib le w ith  physiological action . Changes 
in se n s itiv ity  to  the pressor and steroidogenic actions o f angiotensin II in 
response to  d ie ta ry  sodium and potassium m anipulation may be regu la ted a t the 
receptor leve l. Sodium re s tr ic tio n  has been shown to  decrease the recep to r 
numbers in  vascular smooth muscle, uterus and renal g lom eru li w ith o u t changing 
the a f f in ity  o f receptors and to  increase receptor numbers in the adrenal gland. 
In it ia l ly  adrenal receptor a f f in ity  was increased w ith  sodium re s tr ic t io n  but a fte r  
4 days had returned to  normal (Table 1.2). The d iffe re n tia l e ffe c ts  o f d ie ta ry  
sodium on adrenal and smooth muscle receptors are corre la ted w ith  changes in 
physiological responsiveness; sodium re s tr ic tio n  enhances angiotensin II -  induced 
aldosterone synthesis but reduces pressor ac tiv itie s .
Studies in the ra t  ind ica te  th a t d ie ta ry  potassium has the opposite e ffe c t 
o f sodium on angiotensin I I  receptors. Potassium re s tr ic tio n  increases smooth 
muscle receptor numbers and decrease adrenal receptors whereas potassium 
loading caused a reduction in smooth muscle receptors and increases in  adrenal 
receptors (Table 1.3). Receptor a f f in ity  was not s ig n ifica n tly  a ffe c te d . Changes 
in  receptor numbers in response to  d ie ta ry  sodium or potassium are thought to  
be regulated by plasma angiotensin II concentrations (Aguile ra, Hauger and C a tt 
1978).
Human angiotensin II receptors were f ir s t  demonstrated in aldosterone- 
producing adenomas, adjacent non-tumorous adrenal tissue and norm al human 
adrenal zona glomerulosa (Brown, Douglas and Bravo 1980). Two classes o f 
receptor binding sites fo r  angiotensin I I  were present in norm al tissue obtained
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TABLE 1.2
TH E  E F F E C T  OF D IE T A R Y  SO DIUM  O N A N G IO TE N S IN  I I  B IN D IN G
D IE T TISSUE SPECIES K d Bm ax REFER EN CES
low sodium 
normal sodium
mesenteric
a rte ry
(pa rticu la te
membranes)
ra t 0.79 nM 
1.04 nM
41.5 fm o l/m g  
54.3 fm o l/m g
26
low  sodium 
norm al sodium 
high sodium
urinary
bladder ra t 1.5 nM 
1.3 nM
1.5 nM
60 fm o l/m g  
84 fm o l/m g 
122 fm o l/m g
5
low  sodium 
normal sodium
uterus ra t 2.0 nM 
1.9 nM
27 fm o l/m g 
45 fm o l/m g
27
low sodium 
normal sodium 
high sodium
uterus ra t 0.04 nM 
0.03 nM 
0.05 nM
2.8 pm ol/m g
1.0 pm ol/m g
2.0 pm ol/m g
28
low sodium 
normal sodium 
high sodium
adrenal
glomerulosa ra t 0.02 nM 
0.02 nM 
0.02 nM
0.63 pm ol/m g 
0.33 pm ol/m g 
0.31 pm ol/m g
28
low sodium 
normal sodium 
high sodium
adrenal
glomerulosa ra t 2.0 nM 
1.3 nM 
1.5 nM
45 fm o l/lO ^ce lls  
26 fm o l/lO ^ce lls  
21 fm o l/lO ^ce lls
27 ,29 ,30 ,31
low sodium 
normal sodium 
high sodium
adrenal
cortex ra t
H:1.9 mM 
L:57 uM 
H:2.0 mM 
L:150 uM 
H;1.9 mM 
L:270 uM
ra tio  3.0 
1.0 
0 .7
32
low sodium 
normal sodium 
high sodium
renal
g lom eru li ra t 129 pM 
71 pM 
27 pM
7.87 fm o l/m g  
11.62 fm o l/m g  
17.37 fm o l/m g
20
H : high a f f in ity  s ite  
L : low  a f f in ity  s ite
TABLE 1.3
TH E  E FFE C T OF D IE T A R Y  PO TASSIUM  O N A N G IO TE N S IN  I I  B IN D IN G
D IE T TISSUE SPECIES K d Bm ax REFERENCES
low potassium 
normal potassium
mesenteric
a rte ry ra t 1,4 nM 
1.0 nM
470 fm o l/m g  
316 fm o l/m g
33
low potassium 
normal potassium
uterus ra t 6.0 nM 
3.8 nM
308 fm o l/m g  
148 fm o l/m g
33
normal potassium 
high potassium
uterus ra t 0.23 nM 
0.32 nM
190 fm o l/m g  
110 fm o l/m g
34
normal potassium 
high potassium
adrenal
glomerulosa ra t 0.89 nM 
0.65 nM
1800 fm o l/m g  
3700 fm o l/m g
34
low potassium 
normal potassium 
high potassium
adrenal
cortex
ra t H:2.5 mM 
L;76 uM 
H:2.0 mM 
L:150 uM 
H:0.7 mM 
L:72 uM
ra tio  0.7 
!1 .0
2.0
32
H: high a f f in ity  s ite
L : low  a f f in ity  s ite
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et surgery: a high a ff in ity ,  low  capacity  s ite  (kd =0 . 4' nM, 468 fm o l/m g  prote in ) 
and a low  a ff in ity ,  high capacity  s ite  (kd = 2.5 nM, 1094 fm o l/m g  pro te in ). The 
aldosterone-producing adenomas and adjacent non-tum orous tissue possessed only 
low a f f in ity  receptor sites ( 4 .5 5  nM , 462 + 112 fm o l/m g  pro te in , n = 11) 
and i t  is possible tha t poor aldosterone response to  infused angiotensin II in 
patients w ith  prim ary aldosteronism (due to  an adrenal adenoma) may be re la ted  
to  few er receptor sites fo r  angiotensin II (Fraser, B e re tta -P icco li, Brown, 
Gumming, Lever, Mason, M orton and Robertson 1981).
However a more recent study (Douglas e t a l. 1984) characterised only a 
single class o f angiotensin 11 binding sites in normal human and prim ate adrenal 
glomerulosa and fasclcu la ta  tissue and in  a cortisol-producing adenoma (Douglas, 
Brown and W hite 1984). The authors suggest th a t th e ir  in a b ility  to  de tec t high 
a ff in ity  sites in this la te r study may be re la ted to  the tim e  elapsing between 
tissue rem oval and assay. There were no differences in a f f in ity  between 
fasc lcu la ta  and glomerulosa tissue which is surprising since the stero idogenic 
response to  angiotensin II in the zona glomerulosa is more sensitive than th a t o f 
the zona fasclcu la ta . However, agonist and antagonist analogues o f angiotensin 
II competed fo r  binding sites commensurate w ith  th e ir known b io log ica l a c t iv ity .
Angiotensin 11 has also been shown to  specifica lly, bind to  human g lom eru li 
isolated from  normal kidneys th a t were obtained a t nephrectomy or early  
autopsy (Chansel, A rda illou , N ivez and A rda illou  1982). Two classes o f recep to r 
could be defined by Kd values (0.1 and 1.8 nM) and number o f recep to r s ites (44 
and 303 fm o l/m g  prote in ). The presence o f these receptors in  human renal 
g lom eruli suggest a ro le  fo r  angiotensin II in the regu la tion  o f g lom eru lar 
function  in  man.
A ttem p ts  have been made to  id e n tify  angiotensin 11 receptors in human 
mononuclear leukocytes. In 1978, Shimada and Yazakl reported th a t the binding
o f ^^^I-angiotensin II to  mononuclear leukocytes was rap id  and reversib le. 
Scatchard analysis from  displacement studies indicated tw o  classes o f binding 
sites w ith  dissociation constants o f 5 x lO '^M  and 9 x and w ith  181 and
2,312 s ites /ce ll, respective ly . Fu rthe r studies w ith  mononuclear leukocytes from  
patients w ith  B a rtte r ’s syndrome, renovascular hypertension and prim ary 
aldosteronism showed th a t binding characteris tics were not a lte red  in these 
diseases (Ohuchi, Yazaki, K a to , Ashida and Shimada 1980). More recen tly  
however, Neyses e t al. have raised doubts about the v a lid ity  o f th is work (see 
chapter 3) and in doing so drew a tten tion  to  the c r ite r ia  and biochem ical 
conditions necessary fo r  the id e n tifica tio n  o f a specific  recep to r (Neyses, 
Lecher, Wehling, Pech, Tenschert and V e tte r 1984).
1.4:2 Radiolabelled angiotensin II
There is some argument over the choice o f rad ioactive  label fo r  
angiotensin receptor binding studies. Idea lly  the labelled hormone should have 
the same biological a c t iv ity  as the parent hormone. O rig ina lly  t r i t ia te d  
angiotensin II was used in rabb it aorta (Devynck and M eyer 1976) because i t  
maintained fu ll b io log ica l potency. In  contrast, ^25j.angiotensin I I ,  has only 70% 
o f the pressor a c t iv ity  o f the native  hormone (L in  and G oodfriend 1970). This 
loss o f a c t iv ity  may be due to  a change in the pK o f the phenolic OH o f 
tyrosine (Kurbart, C o li, Vancheri and Rosa 1971). However the use o f ^H - 
angiotensin 11 is lim ite d  by its  re la tiv e ly  low  specific  a c t iv ity  (< 1 0 0  C i/m m o l) 
compared w ith  monoiodinated angiotensin 11 (2,000 C i/m m oI). The spec ific  
a c tiv itie s  o f ^H-angiotensin II are much lower than those o f ^^^-ang io tensin  11 
(M orgat, Hung and From ageot 1970), and hence are more suited to  the 
id e n tifica tio n  o f low  a f f in ity  high capacity sites (see Table 1.1).
Since mono-iodoangiotensin exerts the same physiologic e ffe c ts  as 
unlabelied angiotensin on u terine smooth muscle and ra t adrenal co rtex  (L in  and
Goodfriend 1970) its  use in these tissues a t least Is ju s tif ie d . D i-iod ina ted
angiotensin is la rge ly  inactive  (Kurbart e t al. 1971).
125i_angiotensin has been used to  id e n tify  high a f f in ity  receptors in 
several non-vascular tissues (Table 1.1). In cases o f vascular receptors where 
low binding capacity and re la tiv e ly  sm all amounts o f membrane m a te ria l are 
im portant lim ita tio n s , the use o f high specific  a c t iv ity  125i_angiotensin II is 
ju s tifie d  despite the sm all loss o f b io log ica l a c t iv ity  (Baudouin, Meyer,
Fermandjian and M orgat 1972; Devynck, P erno lle t, M eyer, Ferm andjian and 
Fromageot 1973; LeM orvan and Palaic 1975).
In many tissues however 125i_ and ^H-angiotensin II have been shown to  
be equipotent in binding a f f in ity  (Glossman, Baukal and C a tt 1974b; Gunther, 
Gimbrone and A lexander 1900a). O f pa rticu la r im portance to  the present study, 
Moore and W illiam s (1982) found no s ign ifican t d iffe rence between ^25j_ gnd 
angiotensin II in a f f in ity  fo r  the human p la te le t angiotensin II receptor.
1.5 PURPOSE O F PRESENT STU D Y
The existence and physiological significance o f angiotensin II receptors
have been shown in several tissues from  animals. A lthough s im ila r receptors
have been id e n tifie d  in some human tissues, vascular smooth muscle and adrenal 
cortex are not read ily  available. Accord ingly, p la te le ts have been studied since 
they show high a f f in ity  specific  binding sites fo r  12%-angiotensin II and are 
easily obtained.
The present study has been designed (1) to  show th a t angiotensin II 
binding to  p la te le t receptors is spec ific  (i.e. saturable, reversib le , tim e  and 
tem perature dependent, e tc .) and not due to  endocyto tlc uptake o f a m etabo lite , 
(2) to  examine the e ffe c ts  o f d ie ta ry  sodium and potassium and essential
hypertension on p la te le t binding characte ris tics , (3) to  explore possible 
in tra ce llu la r modes o f action and (4) to  investigate  whether angiotensin II 
binding to  p la te le ts is re la ted  to  any physiological e ffe c t.
C H A P TE R  2 M A T E R IA LS  A N D  M ETHODS
The in it ia l ob jective  was to  develop a method o f preparing p la te le ts  in 
good y ie ld  from  a re la tive ly  sm all blood sample. This was achieved using a 
simple one-step procedure w ith  P erco ll. A density o f P erco ll was chosen such 
th a t p la te le ts  were reta ined and o ther blood cells excluded. The p la te le t
preparation sought to  id e n tify  and characterise angiotensin II binding.
2.1 M A T E R IA LS
2.1:1 Radiolabelled angiotensin II
^2^1-angiotensin II (1-1.6 C i /w g )  was obtained from  New England Nuclear 
(Boston, M A , U.S.A.). This m ate ria l was dissolved in s te rile , T ris-N aC l-BSA 
solution (50 mmol/1 T ris -H C l, 154 mmoI/1 N aC l, 1% bovine serum album in, pH
7.35) and frozen In 350 u l aliquots a t a concentration o f 3 nmol/1 in the dark 
a t -20°C  u n til used, always w ith in  30 days o f preparation. Under these 
conditions, the peptide is stable as assessed by paper chromatography.
2.1:2 Unlabelied angiotensin II
I le ^  -angiotensin II obtained from  Peninsula Laboratories Inc. (San Carlos, 
CA, U.S.A.). This m ate ria l was also dissolved in s te rile , T rls -bu ffe red  saline (pH
7.35) and frozen in 400 p i aliquots in  the dark a t -20°C  u n til used.
2.1:3 Angiotensin analogues
Angiotensin II analogues [Sar^, Thr® ]-Ang II, [ 5 a r \  A la® ]-A ng II,  Ang III 
and Ang I were obtained from  Peninsula Laboratories Inc.
2.1:4 C e ll cu ltu re  medium
Medium 199 was obtained from  F low  Laboratories (Irvine, A yrsh ire , U .K .). 
2.1:5 O ther reagents
O ther reagents used included Perco ll (Pharmacia F ine Chem icals, Sweden), 
disodium ethylenediam inete traaceta te  (EDTA, May and Baker L td ., Dagenham, 
U .K .), bovine serum album in (BSA, M iles Laboratories, U .K .), d ibu ty l phthalate 
and dinonyl phthalate o il (F luka AG , Sw itzerland), acetone (May and Baker L td ., 
Dagenham, U .K .). T rls  (hydroxym ethyl)-m ethylam ine (Tris), sodium c itra te , 
glucose, potassium ch loride, sodium chloride, calcium  ch loride and magnesium 
chloride were a ll obtained from  BDH Chemicals L td ., Poole, U .K .
2.1:6 Tubes and nylon gauze f i l t e r
50 m l centrifuge tubes and 2.5 m l LP -3 tubes were obtained from  
Sarstedt, W. Germany, and 400 p i m icrocentrifuge tubes from  Alpha
Laboratories, U .K . . Nylon gauze f i l t e r  (20 pm) was obtained from  H enry Simon, 
S tockport, U.K.
2.2 METHODS
2.2:1 Preparation o f Percoll
1 l i t r e  o f P erco ll was divided in to  tw en ty  50 m l portions and stored 
a t - 20°C  u n til used.
2.2:2 Preparation o f b u ffe r solution
Tris-N aC l solution was prepared containing (in mmol/1) T rls , 50; NaC l, 
154; C aC l2, 4.8; K C l, 3.6; M gC l2, 1.8. The pH o f T ris  was adjusted to  7.35 and 
stored a t -20°C  u n til used. 1% BSA was added and the pH was adjusted to  
7.35. This solution was frozen and stored a t -20°C  u n til used.
2.2:3 Preparation o f m odified medium 199
M odified medium 199 was prepared containing (in mmol/1) Na"^, 145; K * , 
3.8; Ca2+, 2.54; Mg2+, 1.18; HCO3- ,  24.9; C l" , 128; phosphate, 1.18; S042-, 1.18; 
glucose, 11.1; EDTA, 5. A f te r  equ ilib ra tion  w ith  95% 02:5% CO2» the pH was
adjusted to  7.4. 0 .5%  BSA was added and medium was frozen and stored
at -2 0 °C  u n til used.
2.2:4 Paper chromatography
Pure 125j_angiQtensin II w ith  or w ithou t p la te le t suspension was spotted 
a fte r incubating a t 22°C fo r Ih  on Whatman no. 1 paper. Descending paper 
chromatogram was developed at room tem perature fo r  24 -  36 hours in  a m obile 
phase butano-2-ol/aq. 3% ammonia (120:44, v /v ). A fte r  drying, the paper was 
cu t in to  1 cm long strips and these strips were compressed in to  LP-3 tubes and 
counted using a Nuclear Enterprise NE 1600 gamma counter w ith  90% counting 
e ffic iency.
2.2:5 Preparation o f p la te le ts
Forearm venous blood (60 m l) was co llected  by venepuncture in to  tw o 50 
m l p lastic cen trifuge  tubes each containing 3 m l o f sodium c itra te  (129 mmol/1). 
Im m ediate ly, a t room tem perature the blood was ca re fu lly  layered on to  an iso- 
osm otlc solution o f P erco ll (specific g rav ity  1.060). This so lution was prepared 
from  Percoll (specific  g rav ity  1.130);1.54 M sodium chloride (specific  g rav ity  
1.058), 9:1; which was diluted w ith  an equal volume o f 0.154 M normal saline 
(specific g rav ity  1.000). A fte r  cen trifuga tion  (400 g, 5 m in, 4°C ) the upper 
p la te le t-rich  layer equal to  the volume o f added blood was aspirated, washed 
w ith  an equal volume o f m odified medium 199 and centrifuged (1000 g, 10 m in, 
4°C). This was repeated three tim es w ith  the p la te le t-r ich  layer resuspended in 
15 m l o f m odified medium 199 each tim e . The fin a l aspirate was suspended in 
5-6 m l o f medium and the suspension f ilte re d  through a 20 pm nylon gauze to  
remove aggregates. This f i l t ra te  was used In the binding assays. The p la te le t 
concentration in a sm all portion o f th is suspension was measured in a phase 2 
C oulter counter (S plus). The recovery % o f p la te le ts  from  blood was 50 -  90% 
(n=192) and the p la te le t concentrations ranged from  6 to  10 x 10^ ce lls  per p i.
The fin a l p la te le t suspension contained less than 1% mononuclear leukocytes and 
0.1% red blood cells. The procedures o f p la te le t preparation are shown in 
F igure 2.1.
2.2:6 B inding assay
The technique used fo r  binding studies were m odifica tions o f those 
described by L in  and Goodfriend (1970), Douglas and C a tt (1976) and Moore and 
W illiam s (1982). Suspensions o f p la te le ts (200 p i)  were incubated w ith  25 p i o f 
125i_angiotensin II ( 3 n m o l / l )  in Tris-NaC l-BSA (pH 7.35) w ith  and w ith o u t 
unlabelied angiotensin II (2 5 pm o l/I) in  a f in a l volume o f 250 p i. Unlabelied 
angiotensin II was dissolved in T ris-N aC l solution; p la te le ts incubated w ith ou t 
unlabelied angiotensin I I  were trea ted  w ith  25 p i T ris-N aC l alone. Incubations 
were usually fo r  1 hour a t 22°C In a shaking w ater bath (Gallenkamp, U .K .).
A f te r  incubation, p la te le ts were separated from  medium by cen trifug ing  100 p i
portions o f the incubation m ix tu re  in 400 p i tubes containing 200 p i o f a 
m ix tu re  o f d ibu ty l phthalate and dinonyl phthalate (5:1, v /v ) w ith  a spec ific  
g ra v ity  o f 1.03, a t 12,000 g fo r 30 s in  a m icrocen trifuge  (Beckman). The tubes 
were im m ed ia te ly  frozen in  acetone/solid CO g and cut w ith  a g u illo tin e  ju s t 
below the o il-w a te r in te rface . Both upper and low er portions o f the tube (free  
and bound ra d io a c tiv ity , respective ly) were counted in a Nuclear Enterprise 
NE1600 gamma counter a t 90% counting e ffic ie n cy . These incubation procedures 
are shown in  F igure 2.2.
Nonspecific binding was defined as the amount o f 125j_apgjotensin II
bound to  p la te le ts in the presence o f 25 p i (2 5 pM ) unlabelied angiotensin II.
To ta l binding was defined as the amount o f ^25j_angiotensin II bound to  p la te le ts  
in  the absence o f unlabelied hormone. Specific  binding was defined as to ta l 
binding minus nonspecific binding.
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F IG U R E  2.2  P la te le t binding assay procedure.
2.3 A N A LY S IS  OF B IN D IN G  ISOTHERMS
Scatchard analysis was used to  ca lcu la te  the equ ilibrium  dissociation 
constant (Kd) and the binding capacity (Bmax) from  saturation and com petition  
curves (Scatchard 1949). Binding capacity was calcu la ted from  the concentration 
o f bound ligand a t the in te rcep t o f the regression line  on the abscissa o f the 
Scatchard p lo t. Bmax was expressed as receptor sites per p la te le t using 
Avogadro’s number. Standard k in e tic  analysis was used to  ca lcu la te  the fo rw ard  
and reverse ra te  constants from  association and dissociation experiments 
(Gunther e t al. 1980a). Results fo r  receptor binding capacity and a f f in ity  and 
o ther values are presented as mean + standard e rro r (M + SE). The re la tive  
a f f in ity  fo r  angiotensin analogues were estim ated by comparing the 
concentrations o f non-radioactive analogues required to  displace 50% 125j_ 
angiotensin II from  its  spec ific  binding sites (IC 50). Comparison o f re la tive  
potencies o f unlabelied peptides are presented as dose ra tio . L inear regression 
was ca lcu la ted w ith  the least squares technique (Snedecor and Cochran 1967). 
2.3:1 O ther s ta tis tic a l methods
For group comparisons, student paired and unpaired " t "  tests were used. 
C o rre la tion  coe ffic ie n ts  were estim ated by the Spearman rank m ethod (Siegel 
1956).
C H A P T E R  3 B IO C H E M IC A L  B IN D IN G  C H A R A C T E R IS T IC S  OF
A N G IO TE N S IN  I I  RECEPTO RS IN  H U M A N  P LA TE LE TS
3.1 B IN D IN G  AS A  F U N C T IO N  OF IN C U B A T IO N
TIM E  A N D  T E M P E R A TU R E
3.1:1 Methods
P la te le ts  were incubated w ith  i25j_angiotensin II (300 pM) a t 22°C , 37°C 
and 0°C  fo r  tim e  periods from  5 to  120 m inutes. The reaction  was te rm ina ted  
by m icrocentrifugation .
3.1:2 Results
In tw o experiments a t 37°C , specific  binding o f ^^S j.gpgjotensin II to  
p la te le ts reached a maximum a fte r  30 m in. A  plateau was not sustained and 
spec ific  binding declined the rea fte r (Figure 3.1).
In  each o f five  experiments a t 22°C , specific  binding increased rap id ly  
during the f ir s t  30 m in. and reached a plateau a t 60 m in. Nonspecific  binding 
reached a plateau a fte r 30 min. o f incubation.
In tw o experiments a t 0°C , angiotensin II binding increased s low ly and at 
120 m in. there was 22% o f the binding present a fte r  8 hours.
The specific  binding comprised 1.1 + 0.07% o f to ta l ra d io a c tiv ity  and 
nonspecific binding comprised 0.3 + 0.22% (n = 9) in p la te le ts  incubated a t 22°C 
fo r  60 m inutes w ith  300 pM o f ^25j.angiotensin II.
Because p la te le t concentrations and binding varied between experim ents, 
spec ific  binding was expressed as a percentage o f the maximum binding a tta ined  
during th a t experim ent. In subsequent experiments, spec ific  binding o f 
angiotensin I I  was estim ated a fte r  incubation o f p la te le t a t 22°C fo r  one hour.
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FIGURE 3.1 Time course of specific “125j_angiotensin II binding to 
platelets at 22“C, 37®G and 0°C. The points represent the mean 
and standard error of five experiments at 22®C and means and 
ranges of two experiments at 37°C and 0°C.
3.2 D E G R A D A T IO N  OF T R A C E R  
3.2:1 Methods
The m etabolism  o f trace r in the incubation medium was examined using 
descending paper chrom atography (described in  chapter 2).
3.2:2 Results
Paper chromatography o f the incubation medium a fte r  30, 60 and 120 
m in. o f incubation a t 37°C showed a progressive decline in  the amount o f 
ra d io a c tiv ity  th a t chromatographed w ith  the m o b ility  o f angiotensin II w ith  a 
concom itant increase in the amount o f ra d io a c tiv ity  in o ther positions. L i t t le  
m etabolism  o f angiotensin II by p la te le ts  was detected a t 22°C , over 60 m in. o f 
incubation (Figure 3.2). The m inor changes in R f fo r  125i»angiotensin II were 
observed but were accounted fo r  by uneven solvent flo w . No consistent change 
in R f fo r ^^^I-angiotensin II was noted.
3.3 B IN D IN G  AS A  F U N C T IO N  OF P L A T E L E T  C O N C E N T R A T IO N  
3.3:1 Methods
^^^I-angiotensin II was incubated w ith  a range o f p la te le t concentrations 
from  1.1 X  10^ to  17.2 x 10^ c e lls /u l a t 22°C fo r  90 min.
3.3:2 Results
There was a linear re la tionship between specific  binding and ce ll 
concentration (Figure 3.3). In each o f fou r experim ents the co rre la tion  
coe ffic ien ts  re la ting  to  specific  binding and p la te le t concentra tion were > 0.93. 
Nonspecific binding was less consistently re la ted  to  p la te le t concentra tion than 
specific  binding. A t  p la te le t concentration > 10 x lO ^ /p l the increase in  non-
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F IG U R E  3.2  Temperature-dependent m etabolism  o f 125i_angiotensin I I.  The 
upper panel shows chromatograms o f ra d io a c tiv ity  a fte r  incubation o f tra c e r 
angiotensin w ith  and w ithout p la te le ts a t 37°C fo r  up to  120 m inutes. For each 
chrom atogram, ra d io a c tiv ity  is expressed as a percentage o f to ta l ra d io a c tiv ity  
recovered from  th a t chromatogram. The lower panel shows s im ila r
chromatograms a fte r  60 m inutes incubation a t 2 2 ° C .___ 60 m inutes incubation
w ithou t p la te le ts ;  30 minutes incubation w ith  p la te le ts; . . . 6 0  m inutes
incubation w ith  p la te le ts; - * - 1 2 0  m inutes incubation w ith  p la te le ts . The R f fo r  
i j  ranged from  0.4 to  0.6 in d iffe re n t experiments. [des-Aspl] Ang II, 
Ides-Aspl, A rg ^ ]  Ang II and Ides-Aspl,A rg2 ,V ai5 ] Ang II have an R f value 
greater than Ang II in th is solvent system.
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FIGURE 3.3 Relationship between platelet concentration and 
specific binding of angiotensin II. Each point represents 
the mean and standard error of quadruplicate determinations 
in four experiments. Specific binding is expressed as a 
percentage of total angiotensin II present in the 
incubation medium.
specific  binding was d isproportionate ly steeper. In subsequent experiments 
p la te le t concentration between 5 and 10 x 10^ p la te le ts /u l were used.
3.4 S A T U R A T IO N  OF S P E C IF IC  B IN D IN G
3.4:1 Methods
P late le ts were incubated w ith  a range o f concentrations o f 125[_ 
angiotensin II from  1.6 x 1D"^1 to  2.5 x lO '^M  fo r  60 m in. a t 22°C.
3.4:2 Results
Figure 3.4 shows the cu rv ilinea r re la tionship between spec ific  angiotensin 
II binding and increasing concentrations o f labelled peptide. Specific binding 
sites were saturated a t 0.5 nM whereas non-specific binding was not saturable 
and increased in d ire c t proportion to  the concentration o f angiotensin II. 
Scatchard analysis o f spec ific  binding results from  four sa tura tion  curves gave 
linear plots w ith  an equ ilib rium  dissociation ra te  constants o f 1.5 + 0.4 x 10" 
^^M and a to ta l binding capacity o f 6.3 + 1.2 re ce p to r/p la te le t.
3.5 C O M P E T IT IO N  CURVES
3.5:1 Methods
Labelled angiotensin II in a fin a l concentration o f 300 pM was incubated 
w ith  p la te le ts over a range of concentrations o f unlabelied hormone (3 x 10” ^^ 
to  2.5 X 10“ 6m ) a t 22°C fo r  90 min. Specific binding was expressed as the 
percentage o f 1-25i_angiotensin II binding in  the absence o f unlabelied hormone. 
3.5:2 Results
The amount o f spec ifica lly  bound ra d io a c tiv ity  declined in p la te le ts 
incubated w ith  300 pM 125i_angiotensin I I  and increasing concentrations o f
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F IG U R E  3 .4  E ffe c ts  o f increasing concentrations o f ^^^I-angiotensin II on 
specific  binding. L e f t  panel: each point represents the mean o f fou r
experiments. R igh t panel: Scatchard analysis o f results from  one experim ent, 
B /F=bound/free.
unlabelled hormone (Figure 3.5). The sm allest concentra tion o f unlabelled 
angiotensin 11 tha t reduced binding s ig n ifica n tly  was 5 x (p <0.05); the
IC50 o f unlabelled angiotensin was 1.3 x lO '^M . Scatchard analysis o f the 
results from  six com petition curves gave a Kd o f 2.4 + 0.7 x 10~^^M w ith  a 
binding capacity o f 6.5 + 1.0 recep to r/p la te le t.
3.6 K IN E T IC  STUDIES -  ASSO C IATIO N  CURVES
3.6:1 Methods
Association experiments were perform ed by measuring spec ific  binding o f 
^^^I-angiotensin II to  p la te le ts  a t 22°C fo r  various tim es w ith  ^^^I-ang io tensin  II 
a t concentrations o f 600 and 300 pM. Forward and reverse ra te  constants were 
calcu la ted by a method free  o f assumptions made in the f i t t in g  o f binding 
results to  appropriate ra te  equation (Gunther e t al. 1980a).
3.6:2 Results
The results o f 2 experim ents are shown in Figure 3.6. The equ ilib rium  
dissociation ra te  constant was s im ila r to  values calculated from  sa tu ra tion  and 
com petition studies a t 1.2 x lO '^ O ^ : the forw ard and reverse ra te  constants 
were 3.1 x 10®M“ ^/m in  and 3.6 x lO ’ ^ /m in , respective ly (Appendix 1).
3.7 K IN E T IC  STUDIES -  D ISS O C IA TIO N  CURVES
3.7:1 Methods
Unlabelled angiotensin IT (2.5 pM ) was added to  p la te le t suspension which 
had been preincubated w ith  300 pM ^^^I-angiotensin II a t 22°C fo r  60 m inutes. 
The incubation continued a t 22°C and samples were taken a t various tim e  
in terva ls over a period o f 120 m inutes a fte r  addition o f unlabelled angiotensin II.
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F IG U R E  3.5  P la te le ts were incubated fo r  90 minutes in 300 pM 125j;_angiotensin 
II over a range o f concentrations o f unlabelled angiotensin I I .  L e f t  panel shows 
specific  binding expressed as a percentage o f trace r binding in  the absence of 
unlabelled hormone. Results are given as mean + standard e rro r o f six 
experiments. R igh t panel shows Scatchard analysis o f a representa tive  
experim ent.
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F IG U R E  3.6  K in e tic  studies o f l^S j.ang io tens ln  II association to  p la te le ts . L e f t  
panel; tim e course o f spec ific  binding a t tw o concentrations o f angiotensin 11. 
R igh t panel: angiotensin 11 binding expressed as the na tu ra l loga rithm  o f the 
proportion o f binding a t various tim es (B) re la tive  to  binding a t equ ilib rium  
(Beg). Rate constants were calcu la ted as described in Appendix 1. Values 
shown are the mean o f tw o  experiments, 
o   o 0.6 nM i25 i_ /\ng  II; • ____# 0.3 nM 125 j./\ng jj.
3.7:2 Results
The ra te  o f dissociation o f spec ifica lly  bound ra d io a c tiv ity  is shown in 
F igure 3.7.
The reverse ra te  constant was calcu la ted a t 1.2 x 10-2/m in (Appendix 1).
3.8 S T A B IL IT Y  
3.8:1 Methods
P la te le t suspensions were preincubated w ithou t angiotensin II a t 0°C , 22°C 
and 37°C fo r  periods o f up to  120 m inutes. Specific ^25i_angiotensin 11 binding 
was then measured in the usual way a fte r  incubating the cells a t 22°C fo r  60 
minutes.
3.8:2 Results
The results are expressed as the fra c tio n  o f spec ific  binding w ithou t 
preincubation. Two experiments were perform ed at 3 d iffe re n t preincubation 
tem peratures, 0°C , 22°C and 37°C . Preincubation a t 0°C  had l i t t le  e ffe c t on 
spec ific  binding. A t  22°C  there  was a 30% reduction in  binding a fte r  60 
m inutes and a t 37°C there was a 60% loss o f binding a fte r  20 m inutes (Figure 
3.8).
3.9 S P E C IF IC IT Y  
3.9:1 Methods
P la te le t suspensions were incubated w ith  125j_angiotensin II (300 pM) and 
increasing concentrations (10"^^ -  10"^M) o f various angiotensin I I  analogues.
3.9:2 Results
The dose ratios fo r  the IC5D's in com petition curves were 2.36 fo r
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F IG U R E  3.7  D issociation o f 125j_3ngiotensin II expressed as the na tura l 
logarithm  o f binding a t various times (B) re la tive  to  binding a t tim e  zero (Bo). 
Each point represents the mean o f three experiments. Reverse ra te  constant 
was calcu la ted as described in Appendix 1.
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F IG U R E  3.8  E ffec ts  o f preincubation o f p la te le ts fo r  various tim es a t 0°C , 
22°C and 37°C on specific  binding measured w ith  125i_angiotensin II a fte r  60 
minutes a t 22°C. Results are expressed as a percentage o f the spec ific  binding 
a fte r  60 m inutes a t 22°C  w ithou t preincubation.
[Sar^,Thr® ]-angiotensin I I ,  1 fo r  angiotensin I I ,  0.81 fo r  [des-A sp^]-ang io tens in  II 
(angiotensin III), 0.76 fo r  [Sar^, A la® ]-angiotensin II and 0.11 fo r  angiotensin I 
(Figure 3.9).
3.10 C O R R E C T IO N  FO R  E X T R A C E L L U L A R  F L U ID  C O N T A M IN A T IO N  
3.10:1 Methods
P la te le ts  were incubated a t 22°C w ith  300 pM ^^^I-angiotensin II w ith  
and w ithou t unlabelied angiotensin II fo r  various periods up to  1 hour, together 
w ith  51cr_EDTA (0.1 pC i/incubation) as an ex tra ce llu la r m arker.
3.10:2 Results
The tim e  course o f specific  ^^^I-angiotensin II binding to  p la te le ts  at 
22°C was s im ila r to  th a t found previously. E x trace llu la r rad ioactive  iodine 
associated w ith  the p la te le t pe lle t a fte r  incubation w ith  ^^^I-angiotensin I I  alone 
was s im ila r to  th a t o f p late lets when incubated w ith  ^^^I-angiotensln I I  and an 
excess o f unlabelled peptide (0.39 + 0.02 % compared w ith  0.38 + 0.03%). 
C orrection  fo r  ex trace llu la r f lu id  ra d io a c tiv ity , did not, the re fo re  a ffe c t the 
ca lcu la ted spec ific  binding (1.04% w ith  correction  compared w ith  1.03% w ithou t). 
However, ex tra ce llu la r flu id  contam ination contribu ted  a mean o f 73% to  non­
specific  binding.
3.11 EFFEC T O F D -P H E N Y L A L A N IN E  
3.11:1 Methods
Neyses e t al. have suggested th a t l^S j.ang io tensin  II is degraded by 
carboxypeptidase A in mononuclear leukocytes and th a t the 1 - 7  heptapeptide 
so form ed is taken up by free f lu id  endocytosis in p la te le ts (Neyses, Locher,
100
CMo
om
8 0  -
60 -
40 -
20  -
IC T 'u  10-3 IQ -8
Peptide concentration (M)
F IG U R E  3.9  C om petition by analogues o f angiotensin I I  fo r  125i_angiotensin II 
binding sites. P la te le ts were incubated w ith  300 pM 125i_angiotensin II and 
increasing concentrations o f angiotensin II analogues. Results are expressed as a 
percentage o f trace r binding In the presence o f ^25j_angiotensin II alone and are 
the mean of a t least tw o experiments fo r  each peptide.
A  ▲ Ang I ; ^ . . .  . ^ A n g  II; ■_____# Ang III;
o  0 [S a r i,  A Ia® ]-Ang II; B  ■  I S a rl,T h r8i -Ang II.
Wehling, Pech, Tenschert and V e tte r 1984% Accord ing ly , p la te le ts  were 
incubated w ith  300 pM l^^ I-ang io tens ln  II and increasing concentrations o f 
unlabelled angiotensin II w ith  and w ithou t D-phenylalanine (10 mM) fo r  60 
m inutes a t 22°C. D-phenylalanine a t this concentration is an e ffe c tiv e  in h ib ito r 
o f carboxypeptidase A (Fujioka and Im ahori 1962).
3.11:2 Results
Figure 3.10 presents com petition  curves o f the resu lts. I t  is evident tha t 
spec ific  binding was not a ffe c ted  by inh ib ition  o f the carboxypeptidase A  (D- 
phenylalanine 10 mM). Scatchard analysis showed th a t ne ither the Kd (1.6 x 10*
10 mol/1 vs 2.7 X  10“ 10 mol/1) nor the Bmax (8.3 s ite s /p la te le t vs 9.1
s ites /p la te le t) were a ffe c ted  by D-phenylalanine.
3.12 R EC EPTO R  O C C U P A N C Y
3.12:1 Methods
Experiments were carried  out to  determ ine whether p rio r occupancy by 
endogenous angiotensin II a ffe c ted  the measurements o f binding capc ity .
In the f ir s t  experim ent, com petition  curves were perform ed in  blood from  
3 normal male subjects (ages 32-46 years) before and 2 hours a fte r
adm in istra tion o f the angiotensin converting enzyme in h ib ito r, cap top ril (25 mg) 
by mouth.
In the second experim ent, binding to  p la te le ts from  3 norm al male
subjects (ages 32-36 years) was measured in the usual way and compared w ith  
binding to  p la te le ts from  the same subjects when blood was co llec ted  in to  a 
syringe containing angiotensin II to  give a fin a l concentration in blood o f 1 nM.
In the th ird  experim ent, angiotensin II (4 ng /K g /m in ) was infused fo r  120 
m inutes In three normal male subjects (ages 30 -  37 years). P la te le t angiotensin
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F IG U R E  3.10 C om petition curves o f p la te le ts from  60 m i o f blood from  a 
normal subject incubated w ith  125i_Ang I I  (300 pm ol/I) and increasing 
concentrations o f unlabelled Ang II incubation conditions:-
p la te le ts (5.4 x lo H /1 )  were incubated fo r  60 m inutes a t 22°C  in  medium 199
containing 5 mM E D T A . / \_  /^w ith  10 mM D-phenylalanine, o ____ o w ithou t D -
phenylalanine.
II binding and plasma angiotensin II levels were measured a t the beginning and 
end o f the infusion.
3.12:2 Results
In the f ir s t  experim ent, Scatchard analysis o f the results showed th a t 
cap top ril trea tm en t did not a ffe c t e ithe r receptor concentration (5.9 + 0.8 
s ite s /p la te le t before cap topril; 7.1 + 1.2 s ite s /p la te le t a fte r  cap top ril) or a f f in ity  
(5.4 + 1.5 X  10"10m before cap topril; 5.2 + 1.6 x 10"^^M  a fte r  cap topril).
In the second experim ent, Scatchard analysis o f the results showed tha t 
preincubation o f blood w ith  angiotensin II did not a ffe c t e ithe r receptor 
concentration (4.8 +_ 0.3 s ites /p la te le t before angiotensin I I ;  4.7 + 0.5
s ites /p la te le t a fte r  angiotensin II) or a f f in ity  (6.2 + 1.1 x lO "^ ^ ^  before 
angiotensin II; 5.9 + 0.8 x lO 'l^ M  a fte r  angiotensin II).
In the th ird  experim ent, the plasma angiotensin II leve l was 1 8 + 2  pg/m l 
at the beginning o f in fusion and 80 + 17 pg /m l a t the end. However, these 
short te rm  increases in plasma angiotensin II did not a lte r e ithe r receptor 
concentration (5.5 + 0.5 s ites /p la te le t before angiotensin II infusion; 5.8 + 0.3 
s ites /p la te le t a fte r  angiotensin II infusion) or a f f in ity  (4.7 + 0.3 x 10“ ^^M  before 
and 5.3 + 0.2 x 10"^^M a fte r  angiotensin I I  infusion).
A ll these results are shown in Table 3.1.
3.13 CO M M ENTS
P la te le ts  have been prepared in good y ie ld  (60 + 1.5%, n = 59) fro m  a 
re la tiv e ly  sm all blood sample (60 m l) using a simple one-step procedure w ith  
Perco ll. C en trifuga tion  o f whole blood over a layer o f isotonic Perco ll (spec ific  
g rav ity  1.06> separated p la te le ts (s.g. <1 .06 ) from  other blood cells (s.g.> 1.06), 
contained < 1% leukocytes and < 0.1% eryth rocytes. Most o f the contam inating
TA B LE  3.1
REC EPTO R  O C C U P A N C Y
E F F E C T  OF C A P T O P R IL  A N D  A N G IO TE N S IN  I I  O N 
A N G IO T E N S IN  I I  B IN D IN G
jn  vivo
captopril
trea tm en t
Bmax (s ites /p la te le t ) 
Before A fte r
mean
5.2
7 .8
4.8
5.9
8 .4
8 .8
4 .2
7 .1
Kd (x 10-IO m ) 
Before A f te r
6 .0
8 .2
2 .0
5 .4
7.8
6 .5
1 .4
5 .2
in  v itro  
Ang II 
incubation
mean
5.5
4.7  
4 .4
4 .8
5 .6  
5 .0
3 .6
4 .7
8 .6
5.8
4.1
6 .2
7 .9  
5 .2  
4 .7
5 .9
In  vivo 
Ang II 
infusion
6 .4
4 .4  
5 .6
6 . 6
5 .4
5.5
5.1
4.1  
4 .9
5 .4
4 .8
5.6
mean 5.5 5 .8 4.7 5 .3
leukocytes were mononucleated (80-100%). This lack o f contam ination may be 
o f im portance i f  the repo rt o f Shimada and Yazaki (1978) th a t angiotensin II 
receptors are present in  greater numbers on mononuclear leukocytes than 
p la te le ts are proven. The present method gave a b e tte r y ie ld  w ith  less 
contam ination than th a t o f Moore and W illiam s (1982). I t  is also s ig n ifica n t 
th a t normal spec ific  angiotensin II binding was present in occasional p la te le t 
preparations which contained no measurable contam inating cells.
Scatchard analysis indicated th a t receptor numbers and a ffin it ie s  were 
s im ila r to  those described by Moore and W illiam s (1982). A  single class o f 
spec ific  binding sites on p late le ts was apparent and these sites were saturable. 
Values fo r  the a f f in ity  and number o f angiotensin I I  binding sites fro m  satura tion 
analysis using trace r alone and from  com petition studies using labelled hormone 
were s im ila r, ind ica ting  th a t native and rad ioactive  angiotensin II behaved in  an 
iden tica l manner. Both methods gave a Kd o f around lO '^ ^ M  and a binding 
capacity equivalent to  7 recep to rs /ce ll. Values were not adjusted fo r  the sm all 
losses o f binding capacity  which were observed in pre-incubation studies. The 
Kd is s im ila r to  those described fo r  o ther ta rge t tissue 5 x lO '^^M  fo r  ra t 
m esenteric a rte ry  (Gunther e t al. 1980a) and 0.9-5 x lO '^ ’^ M in anim al adrenal 
cortex (Douglas and C a tt 1976; Aguilera e t al. 1978). Plasma concentrations o f 
angiotensin II may range from  lO '^^M  up to  10"^M across a range o f 
physiological and pathophysiological conditions (Beevers, Brown, Fraser, K ram er, 
Lever, M orton, Robertson, Schalekamp, Sample and Wilson 1976). The binding 
characteris tics described here from  equilibrium  studies are confirm ed by a f f in ity  
calcu la ted from  k in e tic  association and dissociation constants. The dissociation 
ra te  fo r  receptor bound hormone is su ffic ie n tly  rap id  th a t endogenous angiotensin 
II does not a ffe c t binding measurements. P re trea tm en t w ith  cap top ril and 
angiotensin II did not a lte r receptor characteris tics and these results are s im ila r
to  those reported by W illiam s group (Moore, Taylor and W illiam s 19B4).
A recent study by Neyses and colleagues (Neyses e t a l. 1984) suggested 
th a t trace r uptake in to  p la te le ts m ight be due to  free  f lu id  endocytosis ra the r 
than a receptor mechanism. This seems un like ly  fo r  the fo llow ing  reasons: (a) 
Free f lu id  endocytosis o f a ra d io a c tiv ity  was shown at 37°C , a tem pera ture at 
which there is rap id  m etabolism  o f angiotensin II. M y experim ents were carried 
out a t 22°C. (b) There was no evidence o f endocytosis in  experim ents w ith  an
ex tra ce llu la r f lu id  m arker, (c) P la te le t number was una ffected  during incubation 
and on ly in ta c t cells were separated from  medium by cen trifuga tio n  through o il. 
(d) D-phenylalanine, a specific  in h ib ito r o f carboxypeptidase A  prevents free  
f lu id  endocytosis o f metabolised 125i_anglotensin I I  (Fujioka and Im ahori 1962). 
Specific binding o f angiotensin II to  p la te le ts was not reduced by th is  inh ib ito r. 
Mann, Sis and R itz  (1985) have also examined the e ffe c ts  o f a much w ider 
range o f protease in h ib it io r  including L-cyste ine (1.0 mM) and D-phenylalanine 
(0.01-10 mM) and an in h ib ito r o f endocytosis, co lch ic ine  (10-100 pM ) on
angiotensin II binding to  p la te le ts. E ffe c tiv e  in h ib ition  o f protease and
endocytosis did not a ffe c t spec ific  binding o f angiotensin I I  to  p la te le ts.
Therefore, there is no convincing evidence th a t the association o f ra d io a c tiv ity  
w ith  p la te le ts Is due to  metabolism o f ^^^I-angiotensin II by mononuclear
leukocytes and subsequent endocytosis o f th is m etabo lite  in to  p la te le ts .
The a ffin it ie s  o f the p la te le t binding s ite  fo r  analogues o f angiotensin II, 
[S a r i,  Thr® ]-Ang I I  > Ang I I > Ang III>  [S a ri, A la ® ]-A n g  II > Ang I are s im ila r 
to  those described fo r  ra t  adrenal cells.
C H A P T E R  4 EFFEC T OF CH AN G ES IN  D IE T A R Y  SO D IU M  A N D
PO TASSIUM  IN T A K E  O N P L A T E L E T  RECEPTO RS FO R A N G IO TE N S IN  I I
4.1 L A B O R A T O R Y  M ETHODS
Plasma concentration o f renin and angiotensin II were measured by 
radioimmunoassay (M illa r, Leckie, M orton, Jordan and Tree 1980; M orton, 
Sample, W aite, Brown, Lever and Robertson 1976). Renin concentrations were 
assayed by measuring the ra te  o f generation o f angiotensin I in an incubation 
m ix tu re  supplemented w ith  renin substrate. Plasma angiotensin II concentrations 
was measured a fte r  ex trac tion  from  plasma by m ix ing  w ith  Dowex resin fo llow ed 
by e lu tion from  the resin by m ixing w ith  m ethanolic ammonia. U rine 
concentrations o f sodium and potassium were measured using an ion se lective  
e lectrode method (Beckman e lec tro ly te  2 analyser w ith  co e ffic ie n t o f va ria tion  
o f 4%). The method o f p la te le t preparation and radio ligand binding fo r  
measuring angiotensin II receptor concentration and a ff in ity  has previously been 
described in Chapter 2.
4.2 D IE T A R Y  EX PE R IM E N TS
E ight norm al subjects w ith  a mean age o f 31 years (23-37) were studied. 
Each subject was studied a fte r  the fo llow ing  diets: (1) low  sodium (15 m m ol Na, 
70 mmol K /day), (2) normal sodium and potassium (150 mmol Na, 70 m m ol 
K /day), (3) high sodium (200 mmol Na, 70 mmol K /day), (4) low  potassium (150 
mmol Na, 35 mmol K /day), (5) high potassium (150 mmol Na, 150 m m ol K /day). 
The five  diets were given in random order. Each d ie t was given fo r  a period o f 
fou r days w ith  a m inimum  period o f f iv e  days on unrestricted d ie t in  between.
A co llec tion  o f urine was made on the fou rth  day o f each period o f fixed  d ie t 
fo r measurements o f sodium and potassium excre tion  over 24 hours. The 
protocol o f the d ie ta ry  experim ents is shown in F igure 4.1. A t  0900 hours on
the f i f th  day and a fte r  30 m inutes o f recumbency, blood pressure was measured
w ith  a sphygmomanometer. Blood (75 m l) was w ithdraw n by venepuncture from  
a forearm  vein fo r  measurement o f plasma concentrations o f renin and
angiotensin I I ,  and p la te le t angiotensin II receptor concentra tion and a ff in ity .
4.3 S T A T IS T IC A L  A N A LY S IS
For group comparisons. Student's paired ' t '  tests were used. C orre la tion
coe ffic ien ts  were estim ated by the Spearman rank method (Siegel 1956).
4.4 RESULTS
4.4:1 D ie ta ry  sodium
From  urinary sodium measurements, subjects were in  m etabo lic  balance by 
the f i f th  day o f each d ie ta ry  period (Table 4.1). Plasma concentrations o f ren in  
and angiotensin I I  were s ig n ifica n tly  higher a fte r  the low sodium d ie t compared
w ith  e ithe r the norm al or the high sodium d ie t (p< 0.05). As expected there
were s ign ifican t inverse corre lations between urinary sodium excre tion  and
plasma concentrations o f renin and angiotensin II fo r  the th ree  levels o f sodium 
in take (rg 0.64 and 0.65, p < 0.01). Analysis o f the binding curves showed th a t
there was a decrease in receptor capacity (Figure 4.2) a fte r  the  low sodium
d ie t, compared to  the norm al and high sodium diets (p < 0.01) but th a t the re  was 
no change in a f f in ity .  An example o f the e ffe c t o f d ie ta ry  sodium m anipula tion
in one subject is shown in  F igure 4.3; the slope o f the line , a func tion  o f
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F IG U R E  4.1  P rotoco l o f d ie ta ry  experiments.
TABLE 4.1
D IE T A R Y  SO D IU M  A N D  P L A T E L E T  125 i_A N G  I I  B IN D IN G
LOW SODIUM NORM AL SODIUM HIGH SODIUM
15 m m ol/day 150 m m ol/day 200 m m ol/day
Systolic
BP ly ing  101 + 1 100 + 3 104 + 3
(mmHg)
D iasto lic
BP ly ing  61 + 3 62 + 3 59 + 3
(mmHg) ~
PRC (p U /m l) 46 + 5* 24 + 5 16 + 2
pANG II 26 + 2 * *  1 4 + 2  1 2 + 1
(pm ol/1) ~
U rina ry  Na+ 15 + 2 131 + 4 205 + 17
(m m ol/24 hr)
Bmax 4 .1  + 0 .4  6 .2  ^  0 .3  6.8 + 0 .5
(s ites /ce ll)
Kd 5 .2  + 0 .5  5 .4  + 0 .6  4 .1  + 0 .5
(10"^°M )
*  p<  0.05, * *  p < 0.01 compared w ith  normal sodium periods.
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F IG U R E  4 .2  E ffe c t o f d ie ta ry  sodium intake on the concentra tion  o f 
angiotensin II binding sites on p late le ts.
*  paired t ,  p < 0.01, compared w ith  normal and high sa lt periods.
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F IG U R E  4 .3  Scatchard analysis o f angiotensin II receptor binding on high
(#  _____ •  ), normal ( 4 ,  A )  and low  (o_______ o) sodium d ie t in  one subject.
Each po in t represents mean o f quadruplicate determ inations. Values have been 
normalised w ith  respect to  p la te le t numbers (8.0 x ID ^ l/ l) .
a ff in ity ,  does not change whereas the in te rcep t on the abscissa is sh ifted  to  the 
le f t  ind ica ting a decrease in binding capacity.
There was an inverse corre la tion  between plasma concentrations of 
angiotensin II and angiotensin II receptor concentrations (rg 0.57, p < 0.01). 
These results are shown in F igure 4.4. D ifferences in  recep to r capacity  and 
a f f in ity  between normal and high sodium diets were not s ta tis tic a lly  s ign ifican t 
(Table 4.1).
4.4:2 D ie ta ry  potassium
U rinary excretion o f potassium on the f i f th  day o f each d ie ta ry  regime 
was s im ila r to  d ie ta ry  in take (Table 4.2), urinary excre tion  o f sodium was 
una ffected. Plasma concentrations o f ren in  were s ig n ifica n tly  higher a fte r  the 
150 mmol potassium d ie t than a fte r the low and normal potassium diets 
(p <0.05) but the changes in plasma concentrations o f angiotensin II were not 
s ign ifican t (Table 4.2). There were no s ign ifican t changes in  p la te le t receptor 
concentration or a f f in ity  between the three d iffe re n t potassium diets.
4.5 COM MENTS
The e ffe c t o f angiotensin II on aldosterone secretion and blood pressure 
are considerably m odified by changes in d ie ta ry  sodium and potassium. The 
aldosterone response to  angiotensin II is enhanced a fte r  sodium re s tr ic tio n  
(Oelkers, Brown, Fraser, Lever, M orton and Robertson 1974), whereas the pressor 
a c t iv ity  o f angiotensin II is dim inished (W illiams, Hollenberg and B ra ley 1976).
Since the c ircu la ting  concentration o f angiotensin II is increased during 
sodium re s tric tio n , the changes occurring in the adrenal glomerulosa and in  the 
arteries could be m ediated by angiotensin II. Ind irec t evidence suggests th a t 
angiotensin II mediates the a ltered vascular responses to  sodium depletion but is
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F IG U R E  4 .4  R e la tionsh ip  betw een plasma concen tra tions o f  ang io tensin  I I  and 
ang io tensin  I I  re ce p to r concen tra tions.
TABLE 4.2
D IE T A R Y  POTASSIUM  A N D  P L A TE LE T  125 i _a NG  I I  B IN D IN G
LOW POTASSIUM NORM AL POTASSIUM HIGH POTASSIUM
35 m m ol/day 70 m m ol/day 150 m m ol/day
Systolic
BP ly ing  109 + 3 108 + 3 108 + 3
(mmHg)
D iasto lic
BP ly ing  63 + 4 62 + 3 63 + 3
(mmHg)
PRC (u U /m l) 18 + 3 24 + 5 30 + 4*
pANG II 14 + 2 14 + 2 20 + 3
(pm ol/I)
U rinary K+ 41 + 5 68 + 3 142 + 10
(m m ol/24 hr)
U rinary Na+ 134 + 9 131 + 4 149 + 4
(m m ol/24 hr)
Bmax 5 .9  + 0 .3  6 .2  + 0 .3  5 .0  + 0 .2
(sites/ce ll)
Kd 4 .6  + 0 .7  5 .4  + 0 .6  5 .6  + 0 .7
(10-^°M )
*  p < 0.05, compared w ith  normal potassium periods.
responsible fo r  only a sm all pa rt o f the change in responsiveness o f the adrenal 
co rtex . Increased adrenal sens itiv ity  in the low  sodium s ta te  persisted even in 
the absence o f high endogenous angiotensin II by captopril trea tm en t. Thus 
angiotensin II may not be necessary fo r  m ainta in ing the enhanced adrenal 
sens itiv ity  to  infused angiotensin II observed during sodium re s tr ic tio n  in  man. 
In contrast, vascular sens itiv ity  to  angiotensin II during sodium re s tr ic tio n  was 
reversed by lowering o f th e ir  angiotensin II levels a fte r  trea tm en t w ith  cap top ril 
(Dawson-Hughes, Moore, D luhy, Hollenberg and W illiam s 1981). This may re f le c t 
a lte ra tions in  the properties o f angiotensin I I  receptors in response to  changes in 
c ircu la ting  concentrations o f angiotensin II (C a tt, Harwood, Aguilera  and Dufau 
1979).
Radioligand binding studies in ra t  tissue have demonstrated th a t sodium 
depletion reduces the number o f receptor sites in uterine muscle (Devynck e t al. 
1976; Devynck e t al. 1978; Hauger e t a l. 1978), bladder (Aguilera and C a tt  1981) 
and renal g lom eru li (Bellucci and W ilkes 1984) but increases the number o f sites 
in adrenal co rtex  (Douglas and C a tt 1976; Hauger e t al. 1978). In the ra t, 
infused angiotensin II increases both the concentration and a f f in ity  o f adrenal 
binding sites (Douglas and Brown 1982) and th is  increase in adrenal receptors in 
sod ium -defic ien t ra ts  is prevented by cap top ril (Aguilera and C a tt 1978). In  a 
membrane fra c tio n  from  m esenteric a rte r ia l tissue sodium re s tr ic t io n  also 
resulted in a decrease in the number o f recep to r sites (Gunther e t a l. 1980b; 
Aguilera  and C a tt 1981).
In the present study re s tr ic tio n  o f sodium intake fo r  fou r days in  norm al 
human subjects resulted in a decrease in  the concentration o f h ig h -a ffin ity  
binding sites on p la te le ts, thereby con firm ing  the recent observation o f M oore e t 
a l. (Moore, Taylor and W illiam s 1984). Receptor a f f in ity  was not a ffe c te d  by 
d ie ta ry  sodium in take . Changes in recep to r numbers may be m ediated by
angiotensin II since there was a co rre la tion  between the density o f binding sites 
and c ircu la ting  concentrations o f peptide (Figure 4.4). In th is  respect the 
response o f p la te le t angiotensin II receptors to  sodium depletion is lik e  th a t o f 
receptors in  vascular muscle.
D ie ta ry  potassium also a ffe c ts  vascular and adrenal responsiveness to  
angiotensin II in man (Hollenberg, W illiam s, Burger and Hooshmand 1975). 
Reduced potassium intake was associated w ith  a s ign ifican t increase in 
c ircu la tin g  renin a c t iv ity  and angiotensin II concentration and a s ig n ifica n t 
reduction in renal blood flo w . Conversely, a high potassium in take was 
associated w ith  a s ign ifican t increase in plasma aldosterone secretion and renal 
blood flo w  w ithou t a lte ra tio n  in plasma renin a c t iv ity  or angiotensin II 
concentration. Low potassium intake decreased both the renal vascular and the 
adrenal response to  infused angiotensin II, whereas potassium loading enhanced 
the responsiveness o f both systems.
S hort-term  potassium loading in ra ts reduced plasma concentrations o f 
angiotensin II, increased the number o f receptors in the adrenal co rtex  (Douglas 
and C a tt 1976) but decreased the a f f in ity  (Douglas 1979). However, ra t  u terine 
smooth muscle receptors were present in lesser amounts a fte r  d ie ta ry  potassium 
loading (Douglas 1979) and in g reater amounts a fte r potassium re s tr ic tio n  (Pa lie r 
e t a l. 1984). Both potassium loading and re s tr ic tio n  caused an increase in 
receptor a f f in ity  fo r  angiotensin I I.  These e ffec ts  o f potassium loading were 
prevented by adm in istra tion o f cap top ril (Douglas 1980). I t  is s ig n ifica n t th a t 
changes in receptor function  were only observed when plasma angiotensin II 
levels were altered.
In man, d ie ta ry  potassium loading has less consistent e ffe c ts  on plasma 
ren in  a c t iv ity  (Brunner, Baer, Sealey, Ledingham and Laragh 1970) probably 
because o f c o n flic t between the in h ib ito ry  e ffe c ts  o f potassium on ren in  release
(Vender 1970) and the s tim u la tion  o f renin secretion by the netriuresis tha t 
results from  potassium loading (Kahn and Bohrer 1967). There were no 
detectable changes in p la te le t receptor a f f in ity  or concentration in a group o f 
norm al subjects fed diets o f d iffe re n t potassium content. This may be due to  
the lack o f s ign ifican t change in plasma concentration o f angiotensin II in 
response to  potassium loading or res tr ic tio n .
There are several possible explanations fo r  the ce llu la r mechanism of 
p la te le t receptor changes, including; (1). P rio r recep to r occupancy by endogenous 
angiotensin I I .  There are a number o f experiments which have shown th a t p rio r 
receptor occupancy a fte r  short-te rm  in v ivo or in v itro  ' trea tm en t w ith  
angiotensin II does not a ffe c t binding capacity (Chapter 3, Moore e t a l. 1984). 
A lso decreases in binding capacity have been shown to  lag behind increases in 
plasma angiotensin II levels (Moore e t al. 1984). These observations ind icate 
tha t receptor occupancy is not the explanation o f d ie ta ry  sodium-induced 
receptor changes. (2) Synthesis or degradation o f new receptor sites. P la te le ts 
do not have nuclei and are thought not to  be able to  synthesis new prote in . I t  
is possible th a t increased receptors were synthesised by the megakaryocyte 
before separation in to  p late le ts. Increased receptor numbers would then depend 
on p la te le t fo rm ation  but the tim e  course fo r  changes in angiotensin II 
receptor numbers (2 days) is much shorter than the tim e  needed fo r  p la te le t 
turnover (10 days). (3) The degree o f exposure o f already synthesised receptors. 
Unless p la te le ts re ta in  some m inor capacity to  synthesis new prote in  a t least fo r  
a short while, increasing dietary sodium may cause pre-existing 
receptors to be revealed (Moore et al. 1 9 8 4 ) .
C H A P T E R  5 P L A T E L E T  RECEPTO RS FO R  A N G IO TE N S IN  I I
IN  ES SEN TIAL H Y P E R TE N S IO N
5.1 L A B O R A T O R Y  M ETHODS
Methods fo r  measuring renin and angiotensin, sodium and potassium and 
receptor binding are as previously described (Chapters 2 and 4).
5.2 ES SE N TIAL H Y P E R TE N S IO N  A N D  N O R M A L  SUBJECTS
Ten patients w ith  essential hypertension were studied. There were six men 
and four women aged 30-57 years (mean 46) a ll o f whom had at least tw o 
ou tpa tien t blood pressure recordings greater than 150/95 mmHg. P atients were 
on unrestric ted  d ie t and had not previously received drug tre a tm e n t fo r  
hypertension and had not been tak ing any drugs fo r  a t least 4 weeks before  the 
study. A l l patients had normal serum concentrations o f potassium, urea, and 
crea tin ine , w ith  no s ign ifican t p ro te inuria  and normal rap id  sequence intravenous 
urograms. Mean blood pressure, measured tw ice  w ith  a m ercury 
sphygmomanometer a fte r  30 minutes recumbency, was 178 mmHg sys to lic  (range 
152 to  232 mmHg) and 107 mmHg d iasto lic  (range 92 to  154 mmHg). B lood was 
w ithdraw n fo r  measurements o f p la te le t angiotensin binding (60 m l) and plasma 
concentrations o f renin and angiotensin II (15 m l).
The normal subjects were ten age and sex m atched labo ra to ry  o r c lin ic a l 
personnel aged 36-56 years (mean 46) w ith  blood pressure less than 140/90 
mmHg in  the seated position on a t least tw o occasions. Blood pressure was 
measured im m edia te ly before blood sampling. Systolic pressures ranged from  96 
to  122 (mean 112) mmHg and d iasto lic  pressures were between 62 and 86 (mean
74) mmHg. Subjects were not on regular m edication and had taken no 
trea tm en t fo r  a t least 4 weeks before the study.
5.3 S T A T IS T IC A L  A N A LY S IS
For group comparisons, Student’s unpaired *t' test was used.
5.4 RESULTS
Plasma renin and angiotensin concentrations were not s ta tis tic a lly  d iffe re n t 
in the tw o groups although 5 subjects had low -ren in  hypertension.
The binding o f 125i_angiotensin II to  p la te le ts in ID patients w ith  essential 
hypertension was compared w ith  th a t from  10 normal subjects. The number o f 
binding sites and the equ ilibrium  dissociation constants in the 2 groups were 
s im ila r (Table 5.1).
5.5 COM MENTS
In essential hypertension pressor responses to  infused angiotensin II are 
enhanced (Meier, Weidmann, G rim m , Keusch, G luck, M inder and Z ieg le r 1981) 
compared to  normal subjects but the mechanism o f these changes has not been 
defined. One poss ib ility  is th a t changes in the concentration and a f f in t iy  o f 
angiotensin II receptors, perhaps resu lting from  changes in c ircu la tin g  
concentrations o f angiotensin I I ,  may be responsible but o ther mechanisms such 
as changes in geometry o f the resistance vessels have been im p lica ted  (Folkow 
1971).
About 30% o f hypertensive patients have low plasma ren in  concentrations;
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5 o f the patients I  studied had low renin hypertension. Such patients in 
pa rticu la r show enhanced pressor responses to  angiotensin II (M eier e t al. 1981). 
In the patients I studied I could de tec t no changes in e ithe r p la te le t receptor 
a f f in ity  o r concentration. There was no evidence o f receptor up-regulation in 
response to  low  c ircu la ting  levels o f angiotensin. Changes in s e n s itiv ity  to  
angiotensin II In essential hypertension may not be determ ined a t recep to r leve l 
but i t  is also possible th a t changes in  angiotensin receptors in  p la te le ts  do not 
re f le c t changes in vascular muscle.
C H A P T E R  6 EFFEC TS OF A N G IO TE N S IN  I I
ON H U M A N  P LA TE LE TS
Although p la te le ts have receptors fo r  angiotensin II, th e ir  func tion  is not 
c lear. Angiotensin II alone has been reported to  have no d ire c t e f fe c t on the 
aggregation o f normal p la te le ts  when tested over a w ide range o f hormone 
concentrations (S to ff, Stemerman, Steer, Salzman and Brown 198D). However, 
some agents which do not induce p la te le t ac tiva tion  d ire c tly  may po ten tia te  
responses to  other agonists (G rant and Scrotton 1980) and such In te rac tion  may 
be o f pathophysiological im portance.
P la te le t aggregation is in it ia te d  by agonist-receptor in te rac tions on the 
plasma membrane and may be propagated by endogenous p la te le t constituents 
secreted by the activa ted  p la te le ts. Such pro-aggregatory m ediators induce the 
eicosanoids PGG2, PGH2 and TXA2 and the granule constituents A DP and 5HT 
(Kinlough-Rathbone, Packham, Reimers, Cazenave and M ustard 1977) (F igure 6.1). 
The m ajor transduction process th a t links receptor occupancy to  p la te le t 
ac tiva tion  is believed to  be s tim u la ted  phosphoinositlde hydrolysis (M acIntyre , 
Pollock, Shaw, Busfle ld, M acM illan and M cNlchoI 1985): degradation o f
phosphatidylinositol (P td Ins), P td  Ins-4-phosphate or more lik e ly  P td  Ins 4, 5- 
bis-phosphate y ie ld d iacylg lycero l (DAG) and the corresponding Inos ito l phosphate 
(s) (Berrldge 1984). Inosito l 1,4,5 trls-phosphate (Ins P3) has been im p lica ted  in 
Ca^+ m obilisation (Streb, Irv ine , Berrldge and Schulz 1983; Berrldge and Irv ine  
1984). Elevated [Ca^+Jj and DAG are the second messenger m olecules th a t 
regulate the so-called Ca^+.dependent and Ca^^-lndependent pathways o f p la te le t 
ac tiva tion  respective ly (R ink, Sanchez and Hallam  1983) (F igure 6.2).
In order to  determ ine whether p la te le t angiotensin II receptors m odulate 
p la te le t responsiveness to  agonists, the e ffec ts  o f angiotensin I I  on p la te le t
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F IG U R E  6.1  The b iosynthetic  pathways o f prostaglandins. Cyclo-oxygenase is 
inh ib ited  by flu rb ip ro fen . Thromboxane A2 is thought to  be the ac tive  but 
unstable m edia tor o f secondary aggregatory responses. Thromboxane B2 is the 
inactive  but stable product o f thromboxane A2 hydrolysis.
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F IG U R E  6 .2  Regulation o f p la te le t cytoso lic  free  calcium . P la te le t agonists 
(agonist A ) such as vasopressin, throm bin, p la te le t ac tiva ting  fa c to r  (PAP), A  DP 
and 5HT are believed to  cause p la te le t ac tiva tio n  by e levating cytop lasm ic free  
calcium . Agonist B such as prostacyclin and adenosine are believed to  e levate 
cy c lic  AMP levels which may cause p la te le t inh ib ition .
aggregation, cytoso lic  [C a ^+ ]; and TxB2 (thromboxane B2) fo rm a tion  have been 
investigated.
6.1 M A T E R IA LS
5, 6, 8, 9, 11, 12, 14, 15-(^H)N -TxB2 (140 C i/m m o l) in  m ethanol solution 
was obtained from  New England N uclear, Boston, U .S.A.. TxB2 was obtained 
from  Upjohn Co. (Kalamazoo, M ichigan, U.S.A.) was dissolved in  phosphate 
b u ffe r (10 mM, pH 7.3) containing bovine serum albumin (0.1%). A n tl-T x B2 
antiserum  was a g if t  from  D r L . Levine, Brandeis U n ive rs ity , W altham , Mass., 
U .S.A.. 9, ll,-d id e o x y -9 a , lla -epoxym ethano-prostag land in  F2g (U44069, a
thromboxane A2 m im e tic ) obtained from  Upjohn Co. was dissolved in  ethanol and 
kept a t -20°C . Adenosine-5-diphosphate sodium salt (ADP) (Sigma Chem ical Co., 
Dorset, U .K .) were dissolved in 100 mM T ris -H C l, pH 7.35. L-adrenallne 
hydrochloride (ADR) (Sigma) was dissolved in 5% glucose in  w a te r. Stock 
so lution o f Q uin2/AM  (Lancaster Synthesis L td ., Morecambe, U .K .) were made up 
a t 10-50 mM in dry dim ethylsulphoxide (DMSO) (Sigma) and were kept desiccated 
a t -20°C  between use. F lu rb ip ro fen  (Boots p ic, N ottingham ) was dissolved in 
d is tilled  water.
Sepharose 2B was obtained fro m  Sigma Chemical Co..
6.2 P R E P A R A T IO N  OF P L A T E L E T  R IC H  P LA S M A  (P R P ) A N D
P L A T E L E T  PO O R P LA S M A  (PPP)
Blood was co llected  by venepuncture from  the an ti-cub ita l vein o f healthy 
human volunteers, who had not taken drugs th a t a ffe c t p la te le t fu n c tio n  fo r  at 
least 2 weeks. Blood was co llected in to  p lastic  tubes containing 0.1 volume o f 
3.8% tri-sod ium  c itra te  (0.13 M). P la te le t-r ic h  plasma (PRP) was prepared by
cen trifuga tio n  o f the whole blood a t 1000 g fo r  5 m inutes a t room tem perature. 
P la te le t-poor plasma (PPP) was obtained by cen trifuga tion  (3 m inutes, 9000 g, 
2 ( f  C ) o f an a liquot o f p la te le t-r ic h  plasma.
6.3 M EASU R EM EN T OF P L A T E L E T  A G G R E G A TIO N
P la te le t aggregation was measured pho tom etrica lly  in  0.2 m l samples o f 
PRP in a M alin  C lin ica l P la te le t Aggregation Recorder. The mean ce ll count 
was 3.7 + 0.3 x lO ^ /m l. A  typ ica l biphasic aggregation response is shown in 
F igure 6.3. The parameters used to  quantify  the response were as fo llow s:
1. -  the maximum height o f the prim ary aggregation response.
2. R j  -  the maximum ra te  o f change in lig h t transmission during p rim ary 
aggregation.
3. H j  -  the maximum to ta l change in  lig h t transmission (both p rim ary  and 
secondary aggregation responses).
To provide a more quan tita tive  estim ation o f p la te le t aggregation, the 
changes in o p tica l density o f p la te le t-rich  plasma resu lting from  agonist add ition 
were m onitored using a Unicam SP 1800 U ltra v io le t Spectrophotom eter (Pye 
Unicam L td ., Cambridge, U .K.).
B r ie fly , aliquots (0.8 m l) o f p la te le t-rich  plasma were transferred  in to  LP - 
3 tubes and incubated in  a shaking w a te r bath a t 37°C fo r  5 m inutes before the 
add ition o f agonists. A t  appropriate tim e  fo llow ing  the addition o f agonist or 
angiotensin II to  p la te le ts (e.g. adrenaline 5 m inutes, ADP 1 m inute, and U44069 
1 m inute), the sample was p ipetted in to  a 1 cm square quartz cuve tte  and 
absorbance measured a t 600  nm. P re lim ina ry studies indicated th a t the  op tica l 
density o f PRP was proportional to  the concentration o f p la te le ts  in the
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FIGURE 6.3 Schematic representation o f adrenaline-induced p la te le t aggregation 
as m onitored by aggregometry.
suspension. Readings were taken a fte r  addition o f agonists w ith  and w ithou t 
angiotensin II.
6.4 M EAS U R EM EN T OF P L A T E L E T  C Y TO S O LIC  FR EE Ca2+
P la te le t cytoso lic  free  Ca2+ was m onitored using fluorescent quinoline 
dye, Quin 2, which displays high a f f in ity  fo r  Ca2+ and fluoresces as a resu lt o f 
Ca2+ binding (Tsien, Pozzan and R ink 1982). P la te le t-r ic h  plasma was incubated 
(37°C, 30 m inutes) w ith  Quin 2-acetoxy-m ethylester, which read ily  crosses the 
plasma membrane where i t  is rap id ly  hydrolysed by cytoplasm ic esterases to  the 
membrane im permeant polycarboxylate anion th a t is Quin 2. Quin 2 is thus 
trapped inside in ta c t p la te le ts and can report the res ting  concentration o f 
cytosolic free  Ca2+ and changes tha t resu lt from  exposure to  agonists (Rink, 
Smith and Tsien 1982). Quin 2-labelled p late le ts were separated from  plasma 
containing extraneous dye by g e l- f iltra t io n  on columns o f Sepharose 2B 
equilibrated w ith  m odified Hepes-buffered Tyrodes solution (129 mM NaC l; 10.9 
mM Na3 C itra te ; 8.9 mM Na HCO3; 0.56 mM Dextrose; 5 mM Hepes; 2.8 mM 
K C l; 0.8 mM KH2PO^; 0.84 mM M gC l2 and 0.35% bovine serum albumin, pH 
7.4). The Quin 2 content o f p la te le ts was around 1 mmol/1 o f cells. G el- 
f ilte re d  p late le ts were stored a t 37°C in stoppered p las tic  tubes, and, to  
compensate fo r  the chelation o f Ca2+ by c itra te , the external free  calcium  
concentration was adjusted to  1 mM by addition o f C aC l2 im m edia te ly before 
use. P la te le ts  (1 m l) were placed in 1 cm square quartz cuvettes a t 37°C , and 
fluorescence was m onitored in a Perkin E lm er spectropho to fluorim e ter a t 37°C 
w ith  standard monochromator settings o f 339 nm -  e xc ita tio n  and 492 nm - 
emission.
6.5 M EAS U R EM EN T OF TH R O M B O X A N E  Bg P R O D U C TIO N
TxB2 production was measured by radioimmunoassay (M acIntyre and Shaw 
1983). F ive  m inutes a fte r  the add ition o f adrenaline and/or angiotensin II to  the
0.2 m l PRP sample, reactions were te rm ina ted  by the add ition o f 0.4 m l ice - 
cold EDTA (0.4%) in iso-osm otic saline contain ing flu rb ip ro fen  (cyclo-oxygenase 
in h ib itlo r, 30 pM ) and centrifuged (8000 g; 4°C : 3 m inutes). A liquots (0.1 m l) 
o f ce ll- fre e  supernatant was Incubated w ith  0.1 m l an ti-TxB2 antiserum  and 0.2 
m l [^H ] TxB2 (20 nC i) fo r  24 hours a t 4°C . Free TxB2 was absorbed on
dextran-coated charcoal (0.5% charcoal; 0.5% dextran in  10 mM phosphate 
bu ffe r, pH 7.3) and removed by cen trifuga tion  (8000 g: 4°C : 4 m inutes). 
A liquots (0.2 m l) o f ce ll free  supernatant were added to  s c in tilla tio n  vials 
containing s c in tilla tio n  cockta il (T riton ; Toluene: Scintol 2, 12.3; 6.7;1) fo r 
measurement. Bound (^H ]-T xB2 was estim ated in  a Packard T rica rb  544 liqu id  
s c in tilla tio n  counter, and the amounts o f TxB2 generated In the p la te le t samples 
were estim ated from  a standard curve com prising known amounts o f TxB2*
6.6 S T A T IS T IC A L  A N A LY S IS
Results are presented as the mean + SE. S ta tis tica l s ign ificance was 
assessed by Student's p a ire d 't ' test.
6.7 RESULTS
Angiotensin I I  (10*^^ -  10"^M ) has no d ire c t e ffe c t on p la te le t aggregation 
(n = 6) nor did i t  a ffe c t cytoso lic  free  Ca2+ concentration in Quin 2-labelled 
p late le ts e ithe r in the short- ( < 2 m inutes) o r in  the long-te rm  (30 m inutes).
Representative traces o f Quin 2 experiments are shown in F igure 6.4. Low 
concentrations o f angiotensin II (10*^^ -  10"^M) s ig n ifica n tly  enhanced the 
p la te le t aggregating e ffe c ts  o f a sub-maxima! dose o f adrenaline, whereas a 
supraphysiological leve l o f angiotensin II (10"^M) was Inh ib ito ry  (F igure 6.5).
Although there was in te r-sub jec t va r ia b ility  in responsiveness o f p la te le ts 
to  adrenaline and angiotensin II, these e ffe c ts  were observed in p la te le ts  from  
each o f six norm al subjects (Figure 6.6) and appeared to  be confined to  the so- 
called 'secondary' wave o f adrenaline-induced p la te le t aggregation (Table 6.1). 
This was confirm ed by the lack o f e ffe c t o f angiotensin I I  on 'p rim ary ' 
aggregation induced by ADP (data not shown) and by experim ents using the 
cyclo-oxygenase in h ib ito r, f lu rb ip ro fen . The 'secondary' aggregatory response to  
adrenaline is dependent upon endogenous TxA% fo rm ation  and consequently is 
suppressed by flu rb ip ro fen . Angiotensin a t a ll concentrations had no e ffe c t on 
adrenaline-induced p la te le t aggregation when added in the presence o f 
flu rb ip ro fen  (Table 6.1).
I t  is possible th a t the pro-aggregatory e ffec ts  o f angiotensin I I  are 
mediated e ither by an increase ' in TxA.2 synthesis or by a po ten tia tion  o f the 
aggregatory e ffe c ts  o f T xA2« The f ir s t  o f these possib ilities was tested by 
measuring thromboxane 02 fo rm a tion  (the stable product o f T xA2 hydrolysis) in 
response to  adrenaline and angiotensin I I .  Angiotensin I I  alone (10“ ^^M  or 1 0 "  
^M ) did not s ig n ifica n tly  a ffe c t thromboxane B2 fo rm ation . Both concentrations 
o f angiotensin II reduced thromboxane B2 synthesis in adrena line-trea ted  
p la te le ts (Table 6.2). This inh ib ition  would explain the an ti-aggregatory  e ffe c ts  
o f lO '^M  angiotensin II but contrasts w ith  the s tim u la to ry  e ffe c ts  o f 10"^^M 
angiotensin II.
The possib ility  th a t angiotensin I I  potentiates the actions o f TxA,2 was 
investigated using the stable thromboxane A2 m im etic , U44Q69. Angio tensin  II
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FIGURE 6.4 Upper panel; Effects of 9, 11-epoxymethano- 
prostaglandin Hg on platelet [Ca ^ * ] i .  Lower panel: Effect 
of Ang II on platelet [Ca Plasma-free suspensions of
Quin 2-labelled platelets in a modified Hepes-buffered 
Tyrodes solution containing ImM-external Ca 2+ were prepared 
as described in the Methods section. Platelets were 
incubated with angiotensin II at the concentrations indicated 
or saline in control samples, and the fluorescence responses 
(excitation 339 nm, emission 492 nm) were monitored. The 
appropriate intracellular free Ca 2+ calibration scale is 
shown on the right-hand side. The data shown are typical of 
six similar experiments using platelets from different donors.
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F ig u re  6 .5  Typ ica l angiotensin II e ffe c ts  on adrenaline-induced p la te le t 
aggregation. Adrenaline-induced p la te le t aggregation was m onitored a fte r  pre­
incubation w ith  saline (contro l) or angiotensin I I  (at the concentrations ind ica ted) 
fo r  1 m inute before the addition o f adrenaline (5 x XO'^M).
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F ig u re  6.6 E ffe c ts  o f angiotensin II on adrenaline-induced p la te le t aggregation. 
PRP (0.8 m l a liquots) were incubated a t 37°C fo r  5 m inutes before addition o f 
angiotensin II a t the concentrations indicated or saline in  contro l samples. One 
m inute la te r adrenaline, at the concentrations ind icated, was added and the 
resu ltan t decrease in absorbance was m onitored a t 600 nm in  a 
spectrophotom eter.
n  : adrenaline
adrenaline plus angiotensin II 
adrenaline plus angiotensin II IQ-^M 
*  p < 0.05, * *  p <0.01, * * *  p<  0.001
TABLE 6.1
EFFEC TS OF A N G IO TE N S IN  I I  O N A D R E N A L IN E -IN D U C E D  P L A T E L E T  
A G G R E G A TIO N  M EASUR ED B Y  A G G R EG O M ETR Y
PRP alone PLATELET AGGREGATION
H i %1 H t
CONTROL 100 100 100
ANG II 10‘ i lM 104 + 2 98 + 3 139 + 15*
lO - l^M 112 + 4* 110 + 5 137 + 8*
1D-9m 110 + 4* 107 + 3 116 + 4*
10‘ 8m 98 + 5 87 + 4* 9 4 + 4
lO-^M 97 + 5 99 + 5 87 + 5*
PRP w ith  F lu rb ip ro fen
CONTROL 100 100 -
ANG II lO - l^ M 100 + 2 96 + 3 -
id -10m 107 + 3 107 + 5 -
lO '^M 97 + 2 9 6 + 2 -
10-®M 92 + 4 93 + 3 -
10“ 7m 95 + 2 92 + 4 -
P la te le t aggregation parameters H j ,  R ^ and H y  were measured in  PRP in  the 
presence and absence o f flu rb ip ro fen  (30 uM ). Submaximal concentrations o f 
adrenaline (0.5 -  5 uM ) were tested in the presence o f saline (con tro l) or 
angiotensin II a t the concentrations indicated.
Results (mean + SE, n=6) are expressed as a % o f contro l values, *  p<  0.05.
TABLE 6.2
EFFECTS OF ANGIO TENSIN I I  ON AD R E N A LIN E -IN D U C E D  
THROM BOXANE Bg FO R M ATIO N  IN  HUM AN PLATELETS
ADDITION TxBg Cpg/mi)
(M + SE, n=9)
Saline (contro l) 182 + 39
adrenaline f  331 + 45
Ang II 10-^^M 170 + 39
Ang II lO -^M  143 + 27
Ang II lO ’ ^^M + adrenaline 207 + 41*
Ang II 10“ ^M  + adrenaline 140 + 26**
f  The concentration o f adrenaline required to  induce p la te le t aggregation ranged 
from  0.3-5 pM. S ta tis tica l s ign ificance o f reduced TxBg synthesis in  the 
presence o f Ang II and adrenaline compared w ith  adrenaline alone is denoted by 
asterisks: *  p < 0.05, * *  p <0.01.
a t 10"^ ^  and 10"^M  enhanced the aggregatory e ffe c ts  o f a range of 
concentrations o f U44069 (Figure 6.7). The synerg istic e ffe c ts  o f Ang II and 
U44069 were equally apparent in flu rb ip ro fen -tre a te d  p la te le ts.
6.0 COM M ENTS
Angiotensin II has various properties, includ ing actions on a rte r ia l smooth 
muscle, aldosterone secretion and renal func tion . For angiotensin II the 
mechanism th a t links hormone receptor occupancy to  ce llu la r response is 
uncerta in, but i t  m ay involve changes in the cytoso lic  concentra tion o f ionised 
calcium  [Ca^"*] i (Capponi, Lew , Jornot and V a llo tton  1984). E levation  o f 
may be a key regu la tor o f the responsiveness o f numerous ce ll types, 
including vascular smooth muscle (Bolton 1979), adrenal glomerulosa cells 
(W illiam s, M cDougall, T a it and T a it 1981), liv e r (Garrison, Borland, F lo rio  and 
Tw ible 1979), kidney (Fray 1980) and p la te le ts (Gerrard, Peterson and W hite 
1981). One poss ib ility  is th a t angiotensin II binds to  a receptor on the ce ll 
surface, leading to  a change in  plasma membrane s truc tu re , an increase in the 
perm eability  to  calcium  and/or release, o f Ca^+ from  an in tra c e llu la r binding 
sites (Foster and Rasmussen 1983).
The pathophysiological significance o f p la te le t angiotensin I I  receptors and 
the nature o f the transduction process to  which they are coupled are unknown. 
Angiotensin I I  alone appears to  have no d irec t e ffe c t on p la te le t aggregation, 
p la te le t [Ca^'*’] 1 o r p la te le t arachidonate m etabolism  as m onitored as 
thromboxane Eg fo rm a tion : observations which con firm  and extend those o f S to ff 
e t a l. (1980).
A lthough angiotensin II had no d irec t e ffe c t on p la te le t responsiveness, i t  
s ig n ifica n tly  poten tia ted  p la te le t responsiveness to  adrenaline and to  the
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F ig u re  6 .7  E ffec ts  o f angiotensin II on U44069-induced p la te le t aggregation (see 
F igure 6.6 fo r  method).
□  : U44069
^  : U44069 plus angiotensin II 10"H m  
H  : U44069 plus angiotensin II 10"7m 
*  p <0.05, * *  p <0.01
thromboxane Ag m im etic , U44069, but not to  ADP. Angiotensin II potentia tes 
o f adrenaline-induced p la te le t ac tiva tio n  was not associated w ith  increased 
thromboxane Bg fo rm a tion , but was abolished by flu rb ip ro fen , a cyclo-oxygenase 
in h ib ito r. P o ten tia tion  o f U44069-induced p la te le t ac tiva tion  by angiotensin was 
evident both in  the presence and absence o f in ta c t p la te le t cyclo-oxygenase. 
Angiotensin II seems to  po ten tia te  the actions ra ther than the synthesis o f 
thromboxane Ag (or agents th a t combine w ith  thromboxane Ag receptor). The 
mechanism underlying th is  po ten tia tion  is unknown, but is unrelated to  e ffe c ts  o f 
angiotensin II on [Ca^+j i. Angiotensin I I  therefo re  seems to  have tw o  e ffec ts  
on p la te le t aggregation: (1) a t physiological concentrations angiotensin potentia tes 
the e ffe c ts  o f TxAg and the 'secondary' response to  adrenaline; (it) a t 
supraphysiological levels angiotensin inh ib its  thromboxane Ag fo rm a tion .
In conclusion, i t  appears th a t the angiotensin II receptor on p la te le t is 
func tiona lly  active since concentrations o f angiotensin II close to  the 
physiological range (10*^^ -  lO '^^M ) fa c il ita te  p la te le t aggregation. Converting 
enzyme is predom inantly located on the vascular endothelium  and there is 
increasing evidence th a t loca l generation o f angiotensin II in the vessel w a ll may 
be an im portan t process. Concentrations o f peptide in or near the vascular 
endothelium may be appreciably higher than in blood and there Is the po tentia l 
fo r  an in te rac tion  o f angiotensin and adrenaline w ith  p la te le ts a t th is s ite  
tending to  promote thrombus fo rm ation .
CHAPTER 7 GENERAL DISCUSSION A N D  SPECULATION
Conventional radio ligand binding methods have been used in animals to  
examine the properties o f angiotensin receptors in a va rie ty  o f classical ta rge t 
tissues such as adrenal gland (Douglas and C a tt 1976), vascular smooth muscle 
(Gunther a t al. 1980a), bra in (Bennet and Snyder 1980 a &  b) and kidney 
(Osborne, D ro z ,  Meyer and M o r e l 1975). This approach has established tha t 
receptor a f f in ity  end concentration are associated w ith  tissue sens itiv ity  to  the 
physiological actions o f angiotensin II. D ie ta ry  sodium re s tr ic tio n  increases 
receptor number and a f f in ity  in  the adrenal gland, which in  tu rn  renders th is 
tissue more responsive to  the steroidogenic actions o f angiotensin I I  (Aguilera e t 
al. 1978). Conversely, during d ie ta ry  sodium depletion decreases in receptor 
binding in vascular smooth muscle (Gunther e t al. 1980b), dim inish the 
vasopressor action o f angiotensin II (Brown, Casals-Stenzel, Cumming, Davies, 
Fraser, Lever, M orton, Semple, Tree and Robertson 1979). S im ila r studies in 
man are d if f ic u lt  to  perform  because adrenal or vascular tissue connot read ily  
be obtained. I  have demonstrated angiotensin I I  receptors on human p la te le ts 
and th a t the number o f these receptors is a ffec ted  by changes in d ie ta ry  sodium 
intake; high sa lt in take increases and low sa lt in take decreases angiotensin II 
receptor density; a s im ila r response to  sa lt in take occurs in  smooth muscle 
(Gunther e t al. 1980b; Aguilera e t al. 1978) and renal g lom eru li (Be llucci and 
Wilkes 1984). P la te le ts are easily obtained and may be a convenient tissue to  
assess the physiological action o f angiotensin II in man.
C ircu la ting  levels o f angiotensin have been associated w ith  increases or 
decreases in receptor density depending on the tissue under study. In  the 
adrenal co rtex , angiotensin II receptor concentration is up-regulated by sodium 
depletion associated w ith  increases in c ircu la ting  angiotensin II levels (Aguilera
e t al. 1980). However, in vascular, u terine and bladder smooth muscle (Aguilera 
and C a tt 1981), and the renal g lom eru li (Beaufils e t al. 1976; B e llucc i and
W ilkes 1984), sodium depletion is associated w ith  decreases in receptor 
concentration. The mechanism fo r  up-regulation o f angiotensin II receptors by 
c ircu la tin g  hormone in one tissue and down-regulation in o ther tissues is not 
understood. Considerable progress has been made in e luc idating the m olecu lar 
basis o f 6-recep to r desensitisation. Limas and Limas (1984) dem onstrated th a t 
the recovery o f cardiac 6-receptors from  isoproterenol-induced apparent loss 
(down-regulation) is due to  re incorpora tion  o f the in ternalised receptors in to  the 
plasma membrane. Recovery o f in terna lised cardiac 6-receptors (receptosomes) 
does not depend on ^  novo pro te in  synthesis but is an energy-dependent
process, prevented fay m etabolic inh ib ito rs . Several structures such as lysosomes, 
Golgi apparatus and m icrotubules are involved in th is in tra ce llu la r receptor
recyc ling  process. The in te g rity  o f the recovery phase o f receptor cyc ling  is 
very  im portan t fo r  m aintaining the normal complement o f membrane-bound 
receptors, since the tu rn  over ra te  o f cardiac 6-receptor is norm ally  slow (P itha , 
Hughes, Kusiak, Dax and Baker 1982). The a lte rna tive  mechanism, ^  novo
synthesis, may be u tilised  under pathological conditions. No comparable studies 
have been described fo r  the angiotensin II receptor but the mechanism o f up­
end down-regulation may be s im ila r. P la te le ts  have no nucleus and re ta in  only 
a modest capacity fo r  prote in synthesis. The down-regulation o f angiotensin II 
receptors in response to  sodium depletion may involve a lte ra tions in recep to r 
recyc ling  ra ther than a lternations in  receptor synthesis.
Measurements o f cytosolic free  Ca2+ in  in ta c t bovine adrenal glomerulosa 
ce lls w ith  a fluorescent calcium  ind ica to r Quin-2 suggest th a t cytoso lic  Ca2+ is 
increased by angiotensin II and may mediate the e ffe c t o f th is peptide on 
aldosterone secretion (Capponi e t a l. 1984). The mechanism may involve opening
o f receptor-operated calcium  channels or release o f ca lc ium  from  in trace llu la r 
stores through e ffec ts  on phospholipid metabolism (Farese, Larson, Sabir and
Gomez-Sanchez 1983). There are tw o facto rs  which m ediate the e ffe c ts  o f the
hormone on p la te le t aggregation. A  rise in in trace llu la r Ca2+ promotes p la te le t 
aggregation whereas a rise in cyc lic -A M P  inh ib its  p la te le t aggregation. I could 
de tect no increase in [Ca2+] -, in  p la te le ts trea ted  w ith  angiotensin II but I have 
not measured the e ffe c t o f angiotensin II on cyc lic -A M P . A nother poss ib ility  is 
th a t the Quin-2 method cannot de tec t sm all changes in  in tra c e llu la r free  
calcium  necessary fo r  a fa e ll ita to ry  e ffe c t o f a hormone on p la te le t aggregation.
The id e n tifica tio n  o f plasma angiotensin II as a regu la to r o f p la te le t 
angiotensin II receptor provides a po ten tia l experim ental approach to  the study 
o f angiotensin II receptor regu la tion in diseases such as juven ile  diabetes 
m ellitus, prim ary aldosteronism, renovascular hypertension and B a rtte r's  
syndrome.
The incidence o f throm bo-em bolic com plication in patients w ith
hypertensive cardiovascular disease is higher than in the norm al population. 
P la te le t aggregation is the prim e event in thrombus fo rm a tion , especia lly in 
diseased arteries. Under some circumstances there may be an in te rac tio n
between angiotensin II and adrenaline adjacent to  the blood vessel w a ll to 
prom ote p la te le t aggregation and thrombus form ation .
APPEN D IX  1
ANALYSIS OF R AD IO LIG AN D  B IN D IN G  D A TA
1) D e te rm ina tion  o f k in e tic  constants by the in tegra ted ra te  equation 
methods.
Binding o f ^^^I-A ng II was measured as a function  o f tim e  a t tw o
concentrations o f ^^^I-A ng II. For each concentration, the binding data was
transform ed as;
Bt-—ÿ In  (Beq-BtVBgq
where Bj. = ^^^I-A ng II bound a t tim e  t
Bgq = 125]_Ang II bound a t equ ilib rium
and the transform ed data p lo tted  against tim e . A  s tra igh t line  was f i t te d  to  
each set o f data by least-squares method and the slopes calcu la ted (F igure 3.6). 
The fo rw ard  and reverse ra te  constants were then obtained by solving the 
simultaneous equations;
51 = -(K f.[H ] i+Kp)
52 = -(Kf.[H] 2+l r^^
where Sj^, $2 = slopes o f the f it te d  lines 
[ H ] i ,  [ H ]2 = l^ ^ I-A n g  II concentrations 
K f  = forw ard ra te  constant 
Kj. = reverse ra te  constant
i.e . K f  = (5i-S 2) / ( [H ]2- [H ]  1)
K f = (S2-[H] i -Si .j H ]2 )/([H ]2 -[H ] i )
The deriva tion o f th is  method has been described by Gunther e t a l. (1980a).
2) D ire c t determ ination  o f the reverse ra te  constant.
Follow ing incubation under standard conditions, the fo rw ard  reaction  was 
blocked by add ition o f excess unlabelled Ang II end dissociation o f bound 125J. 
Ang I I  measured as a function  o f tim e . The binding data was p lo tted  as In  (B f) 
against tim e  and the slope (= -Kp) ca lcu la ted by least-squares method (Figure 
3.7).
3) D e term ina tion  o f equilibrium  constants
Binding o f ^^^1-Ang II was measured as a function  o f 125i_/\ng u  
concentration under equ ilibrium  conditions (saturation studies) and the binding 
data p lo tted  as bound/free against bound according to  the method o f Scatchard 
(1949). A  s tra ig h t line  was f it te d  by least-squares method and the dissociation 
equ ilibrium  constant (= -1/slope) and Bmax (= abscissa in te rcep t) determ ined 
(Figure 3.4). A lte rn a tive ly , binding o f ^^^I-A ng  I I  was measured as a function  
o f unlabelled Ang I I  concentration (displacement studies) under equ ilib rium  
conditions and values o f bound corrected fo r  the reduction in  specific  a c t iv ity  o f 
the trace r caused by addition o f unlabelled Ang II. This yielded sa tura tion  
curves which were analysed as described above (Figure 3.5).
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